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 CHAPTER I 
 
INTRODUCTION 
 
Overview of transcription initiation  
RNA polymerase is a large, multisubunit protein complex that catalyzes 
transcription or, the synthesis of RNA from a DNA template. There are three major 
classes of RNA. The first class consists of ribosomal RNAs (rRNAs); these RNAs are 
involved in the formation and function of ribosomes, which are large, multisubunit 
complexes of RNA and protein that catalyze translation or, the synthesis of protein from 
an RNA template. The second type of RNA is transfer RNAs (tRNAs); these RNAs 
deliver amino acids to the ribosome and, thus, are critical for translation as well. The 
third class of RNAs is messenger RNAs (mRNAs); these RNAs serve as the templates 
from which all proteins in the cell are synthesized from. 
Each of these classes of RNA is transcribed by a distinct RNA polymerase. RNA 
polymerase I transcribes rRNAs, RNA polymerase II transcribes mRNAs, and RNA 
polymerase III transcribes tRNAs as well as a range of other small RNA molecules 
(Figure I-1). Out of these three polymerases, RNA polymerase II (RNA Pol II) has been 
the most intensively studied. 
Proteins are the essential workhorses of the cell, providing both cellular structure 
and function. The three dimensional structure of proteins is critical for protein function. 
The three dimensional structure of a protein is dictated by that protein’s amino acid 
sequence. In many cases, mutations in a protein’s amino acid sequence can disrupt  
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Figure I-1. A distinct RNA polymerase transcribes each class of RNA. The arrows in 
the figure denote transcription initiation sites. RNA Pol = RNA polymerase. 
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 or alter the three dimensional structure of a protein such that the function of a protein is 
disrupted or altered in undesirable ways. Changes in the function of individual proteins 
can impair cellular structure and function. Such mutations in the amino acid sequence can 
result from mutations in the mRNAs from which proteins are translated from or in the 
DNA from which mRNAs are transcribed. Therefore, it is important that the cell 
transcribe mRNAs accurately, and that DNA is replicated correctly during each cell 
division. The cell has evolved elaborate mechanisms to ensure proper mRNA 
transcription and proper DNA replication. In this thesis, I will focus on the regulation of 
mRNA transcription.  
mRNA is transcribed from a DNA template known as a gene. The process of 
mRNA transcription from individual genes can be divided into three stages: initiation, 
elongation, and termination. During initiation, RNA Pol II binds upstream of the start 
codon at a location known as the promoter. During elongation, RNA Pol II traverses the 
gene and synthesizes RNA in response to the template base sequence.  During 
termination, RNA Pol II dissociates from the gene at a specific termination site, and 
releases the finished mRNA transcript (Figure I-2).  
The process thus described appears to be deceptively simple, but in reality, RNA 
Pol II faces two formidable barriers to accurate transcription. First, the enzyme itself is 
unable to identify the promoter selectively; therefore, RNA Pol II requires assistance in 
locating the correct initiation site on a gene.  Second, DNA is not found naked in the 
nucleus; DNA is packaged with large complexes of histone proteins known as 
nucleosomes to form chromatin. Nucleosomes can effectively mask the  
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Figure I-2. Transcription can be divided into three stages: initiation, elongation, and 
termination. First, during initiation, RNA Pol II binds near the transcription initiation 
site of a gene, which is marked with an arrow. Second, during elongation, RNA Pol II 
synthesizes RNA from DNA as it travels along the gene. Third, during termination, RNA 
Pol II dissociates from the gene at a specific termination site, releasing a complete RNA 
transcript.  
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 initiation sites on genes as well as impose a steric barrier to elongation and, therefore, are 
generally repressive to transcription. 
To help RNA Pol II overcome each of these barriers, the enzyme utilizes 
accessory protein factors.  Protein factors known as general transcription factors (GTFs) 
locate and bind near the transcription initiation site on a gene (Figure I-3).  GTFs, in turn, 
recruit RNA Pol II to the transcription initiation site through direct interactions with the 
enzyme. Additional protein factors disrupt the structure of the nucleosomes such that the 
initiation sites on genes are exposed and available for interaction with GTFs and RNA 
Pol II. These protein factors often function as large multisubunit complexes known as 
chromatin remodeling complexes (Figure I-3).  
In this thesis I will focus on the mechanisms by which GTFs regulate the accurate 
initiation of gene transcription. In order to understand how GTFs function, however, it is 
important to understand the structure of a gene itself. A typical gene is composed of 
several different types of elements. The actual portion of the gene from which mRNA is 
transcribed from is known as the coding region. The transcription initiation site is located 
upstream of the start codon, and downstream of the coding region is the transcription 
termination site.  DNA upstream of the transcription initiation site is defined broadly as 
the promoter. The portion that is immediately upstream (up to ~100-200 base pairs) and 
flanking the transcription initiation site is known as the core promoter. DNA further 
upstream but directly adjacent to the core promoter is known as the proximal promoter. 
Finally, especially in complex organisms, there are specific DNA elements known as 
enhancers that can exist at long distances and are not immediately contiguous with the 
gene itself (Figure I-4).  
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Figure I-3. Accessory protein factors assist RNA Pol II in mediating transcription.  
(Top) Chromatin remodeling complexes alter the structure of chromatin to render the 
transcription initiation sites of genes accessible to RNA Pol II. In the figure, the black 
line depicts DNA whereas the light brown spheres depict complexes of histone proteins 
around which DNA is wrapped.  
(Bottom) General transcription factors, or GTFs, assist in recruiting RNA Pol II to the 
correct transcription initiation site of a gene. The arrow denotes the transcription 
initiation site.  
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Figure I-4. The transcription of each gene is regulated by regulatory DNA 
sequences, the promoter and the enhancer. Shown is a schematic of a typical gene 
promoter.  The transcription initiation site is indicated by the arrow and is denoted +1. 
The core promoter flanks the transcription initiation site and can extend up to 100 to 200 
base pairs upstream of the transcription initiation site. Further upstream and directly 
adjacent to the core promoter is the proximal promoter. Finally, enhancers can exist at 
great distances and may not be continuous with the proximal promoter itself.  
 
 
 7
 GTFs function at the core promoter. There are six GTFs (TFIIA, TFIIB, TFIID, TFIIE, 
TFIIF, and TFIIH). The GTFs, along with RNA Pol II and the DNA at the transcription 
initiation site, form the preinitiation complex, or PIC. The process of PIC formation 
begins with the binding of TFIID to specific sequences in the core promoter. TFIIA 
contributes to the stabilization of the binding of TFIID to the core promoter. TFIIB is 
recruited next into the complex, followed by TFIIF and RNA Pol II, and finally, by TFIIE 
and TFIIH. TFIIH then phosphorylates the largest subunit of RNA Pol II; upon 
phosphorylation, RNA Pol II dissociates from the rest of the PIC. Adenosine triphosphate 
hydrolysis facilitates the opening of the DNA helix and RNA Pol II, along with TFIIE 
and TFIIH, proceeds to move along the gene and catalyze transcription (Figure I-5) (1).   
 
Overview of transcription activation 
Accurate initiation of transcription is crucial to ensure that mRNAs of the correct 
sequence and size are produced. Accurately transcribed mRNAs will be translated into 
proteins that can carry out the myriad of functions that are crucial to cellular structure and 
function.  
However, it is not enough that correctly functioning proteins are produced. For a 
cell to function smoothly, it must be able to produce each protein at the optimal 
concentration needed for efficient function. The optimal concentration of a given protein 
is determined by environmental factors, which fluctuate constantly. Cells have evolved 
mechanisms to sense these environmental factors, and to respond to changes in these 
factors by upregulating or downregulating the concentrations of certain proteins.  
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Figure I-5. 
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Figure I-5. (continued) 
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 Figure I-5. Formation of the preinitiation complex, or PIC, is a complex process. . 
Preinitiation complex (PIC) formation begins with TFIID binding to the core promoter. 
TFIIA contributes to the stabilization of the binding of TFIID to the core promoter. Next, 
TFIIB is recruited to the core promoter, followed by RNA Pol II and TFIIF. Finally, 
TFIIE and TFIIH are recruited into the complex. TFIIH catalyzes the phosphorylation of 
the C terminal domain (CTD) of the largest subunit of RNA Pol II. Upon 
phosphorylation, RNA Pol II, TFIIE and TFIIH dissociate from the rest of the PIC. RNA 
Pol II, along with TFIIE and TFIIH, catalyzes RNA transcription in response to the 
template base sequence as it travels along the gene. In each panel, the arrow denotes the 
transcription initiation site.  
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 Improper adjustment of concentrations of proteins can have deleterious 
consequences. For example, many cancers may arise due to the inappropriate 
overexpression of oncogenes; elevated expression of these oncogenes results in 
unrestrained cellular proliferation, thus leading to tumorigenesis.    
The concentration of a specific protein can be regulated at several points in the 
protein production pipeline. Protein levels can be adjusted by regulating protein stability, 
translation rate, mRNA stability, and mRNA transcription. In this thesis, I will focus on 
the regulation of protein concentration at the level of mRNA transcription.  
As discussed in the preceding section (Overview of transcription initiation), 
GTFs recruit RNA pol II to the correct transcription initiation site of a gene, thus 
ensuring that accurately initiated mRNA transcripts are produced. In addition to, and 
concomitant with, their function in accurately initiating transcription, GTFs also function 
to regulate the mRNA levels of a gene. GTFs do this through interaction with another 
class of proteins, transcription factors. Transcription factors are proteins that recognize 
and bind to specific DNA sequences in the proximal promoter and in enhancers. 
Transcription factors stimulate gene transcription by interacting with and recruiting 
components of the PIC and/or chromatin remodeling complexes.  
 Interaction between transcription factors and PIC components result in several 
consequences, including: increased recruitment of PIC components to the core promoter; 
stabilization of GTF binding to the core promoter; and conformational changes in GTFs 
that stimulate their function. The net result is an increase in the levels of transcript 
produced. Transcription factors themselves are regulated, either directly or indirectly, by 
changes in the cellular environment. Depending on the environmental context, the 
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 binding of a transcription factor at the proximal promoter or enhancer can increase or 
decrease, resulting in increases or decreases in transcript levels, respectively (Figure I-6).   
The transcription level of each gene is regulated in a unique way. This arises from 
the properties of the gene promoter and of the transcription factors themselves. First, a 
given transcription factor can recognize and bind efficiently to DNA elements of a 
specific sequence (some degeneracy or limited variation may be allowed). The proximal 
promoter of a given gene contains only a subset of transcription factor recognition sites, 
thus rendering each gene responsive to only a subset of transcription factors. Second, 
each given transcription factor responds to only a subset of environmental signals and, 
among transcription factors that respond to the same environmental signal, the manner in 
which a given transcription factor responds (either positively or negatively) and to what 
extent, differs. As a result, each gene is responsive only to certain environmental cues, 
and responds to different environmental cues by either increasing or decreasing levels of 
transcription to different extents in a way that is dependent on the details of the 
promoter’s DNA sequence.  
 
The role of TFIID in the regulation of transcription initiation  
TFIID is a large protein complex composed of the TATA-box binding protein 
(TBP) and fourteen tightly bound TBP-associated factors (TafIIs). The structure and 
function of TFIID has been highly conserved throughout eukaryotic evolution. Homologs 
of TBP and all but one of the TAFIIs exist in a spectrum of eukaryotic species, from the  
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Figure I-6. Transcriptional output is increased in response to binding of 
transcription factors to the proximal promoter and enhancers.  Shown is a schematic 
depicting the simple scenario in which transcription of a gene is upregulated in response 
to binding of transcription factors in the proximal promoter and enhancer.  
a. In the absence of environmental cues, no transcription factors are bound to the 
proximal promoter and enhancer, and there is no transcriptional output.  
b. In response to a subset of environmental cues (designated A, B, and C), transcription 
factors bind to their cognate binding sites in the proximal promoter and the enhancer.  
c. Transcription factors bound to the proximal promoter and the enhancer increase the 
formation and/or stabilization of the PIC, thus resulting in an increase in transcriptional 
output. In each panel, the arrow denotes the transcription initiation site.  
TF = transcription factor; PIC = preinitiation complex. 
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 budding yeast, Saccharomyces cerevisae, to Drosophila melanogaster to Homo sapiens 
(2,3). Furthermore, the trilobed, three-dimensional structure of S. cerevisiae TFIID is  
nearly superimposable on the three-dimensional structure of H. sapiens TFIID (4). Lastly, 
TFIID functions to regulate gene transcription by similar mechanisms in S. cerevisiae, D. 
melanogaster, and H. sapiens (1, 5, 6, 7, 8, 9, 10, 11).  
As discussed in Overview of transcription initiation, the process of PIC 
formation begins with the binding of TFIID to specific sequences in the core promoter. 
The binding of TFIID to the core promoter is thought to be the rate-limiting step in PIC 
formation, and this step can stimulated by certain transcription factors. In this way, TFIID 
plays a central role in regulating both the accurate initiation of gene transcription and the 
level of transcriptional output.  Below, the mechanisms by which TFIID is thought to 
regulate both these aspects of transcription will be discussed separately.  
 
Role of TFIID in core promoter selectivity  
 Initial studies of TFIID function indicated that TFIID recognized and bound to a 
consensus DNA sequence, known as the TATA box, in the core promoter (1). 
Recognition of the TATA box is mediated by TBP, a subunit of TFIID, which binds the 
TATA box with high affinity. The TATA box is typically found within 25 base pairs 
upstream of the transcription initiation site in metazoans but, in yeast, can even be as far 
as 100 base pairs away. However, TFIID can also bind to core promoters that do not 
contain a consensus TATA box. In addition, some TafIIs can contact DNA directly, 
usually immediately downstream of the transcription initiation site, but the sequence 
specificity of such interactions is not well understood. These TafII-DNA contacts are 
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 thought to increase the affinity of TBP to core promoters that do not contain a consensus 
TATA box. Furthermore, TFIID does not bind to all core promoters that have a 
consensus TATA box. Lastly, another GTF, TFIIA, is thought to contribute to stabilizing 
TFIID binding to the core promoter. Once bound to the core promoter, TFIID recruits, 
either directly or indirectly, the remainder of the components of the PIC.  
However, TFIID is not required in regulating transcription of all genes inside the 
cell. For example, in a series of promoter-manipulation studies performed by Shen et al. 
(9), it was shown that while transcription from the ADH1 core promoter was not 
regulated by TFIID, transcription from the core promoters of RPS5, RPS30, and CLN2 
was regulated by TFIID. The differences could not be explained simply by the presence 
or absence of a consensus TATA box, as the ADH1 core promoter contains a consensus 
TATA box, whereas the RPS5 core promoter does not contain a consensus TATA box. 
The mechanisms by which PIC formation occurs on TFIID-independent promoters are 
not well understood.   
 
Role of TFIID as coactivator  
 Initial in vitro studies of TFIID function indicated that TBP alone could support 
PIC formation and accurate initiation of transcription. However, the TafIIs were necessary 
for the stimulation of gene transcription mediated by transcription factors (1). The 
concept and definition of coactivator was developed from these in vitro studies on 
activated gene transcription. A coactivator possesses the following characteristics: first, 
the coactivator and transcription factor must directly interact with each other; second, 
interaction between the coactivator and transcription factor is necessary to recruit the 
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 coactivator to the core promoter; and third, interaction between the coactivator and 
transcription factor is necessary to drive stimulation of gene transcription mediated by the 
transcription factor (Figure I-7).   
The ability to assemble TafII-TBP complexes in vitro, using purified recombinant 
proteins, allowed detailed biochemical dissection of the role of individual TafIIs in 
response to transcription factors (1, 5, 7). Two key points came out of this work. First, an 
intact TFIID complex was not necessary to mediate responses to transcription factors. 
Instead, only a subset of TafIIs was required to mediate transcription in response to 
transcription factors. Second, different transcription factors required different subsets of 
TafIIs to stimulate transcription.  
There are several caveats, however, to these in vitro studies. First, the promoters 
that were used to drive transcription were oversimplified, artificial constructs consisting 
of a core promoter and a proximal promoter containing multiple binding sites, in tandem, 
of only one transcription factor. Regulation of transcription of naturally occurring genes, 
however, is much more complicated. Transcription from naturally occurring genes is 
often stimulated by a combination of different transcription factors. The proximal 
promoters of these genes, therefore, contain binding sites for several different 
transcription factors. Furthermore, multiple copies of a binding site for a given 
transcription factor may exist in the promoter but they may not be in tandem with each 
other, and may even be separated by a distance of 100 base pairs or more. Second, these 
in vitro studies largely ignored the contributions from distal enhancers.  
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Figure I-7. TFIID functions as a coactivator for transcription factors. Shown is a 
simple schematic depicting the coactivator model of TFIID. 
a. A transcription factor binds to its cognate binding site in the proximal promoter in 
response to an environmental cue.  
b. The transcription factor recruits TFIID to the core promoter through direct interactions 
with a subset of TFIID subunits. 
c. TFIID nucleates the formation of the PIC, thus resulting in an increase in 
transcriptional output. In each panel, the transcription initiation site is denoted by an 
arrow and +1.  
TF = transcription factor; PIC = preinitiation complex.  
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 The third caveat is that these simplified in vitro systems were used to study only 
one set of interactions, between that of a single transcription factor and a single TafII-TBP 
complex. The ability of mutated transcription factors to bind a particular subset of TafIIs 
was correlated with the ability of these mutant transcription factors to stimulate 
transcription via that subset of TafIIs. For example, the transcription factor, p53, can 
interact with Taf6p in vitro via its transcriptional activation domain. Mutations in the 
activation domain of p53 disrupt interaction with Taf6p (7). Not surprisingly, p53 
requires a minimal TafII-TBP complex that must containTaf6p to stimulate transcription 
in vitro, and again as predicted, the mutant p53 that was defective in interacting with 
Taf6p could not stimulate transcription via this minimal TafII-TBP complex containing 
Taf6p. Therefore, the conclusion was drawn that p53 requires interaction with Taf6p to 
stimulate transcription. Of course, the situation is more complex in vivo, as different 
transcription factors work together to stimulate gene transcription. Because distinct 
subsets of TafIIs mediate interaction with different transcription factors, altering one set 
of interactions by mutating a single transcription factor   may provoke a change in other 
sets of interactions mediated by other transcription factors that could lead to changes in 
gene expression in vivo that could not be predicted from studying one set of interactions 
in vitro. 
Therefore, an important question is:  how exactly does TFIID stimulate 
transcription in vivo? One hypothesis is that TFIID stimulates transcription in vivo as it 
does in vitro, that is, via mutationally sensitive, direct interactions between a given 
transcription factor and a subset of TafIIs.  
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 Evidence that TFIID may serve as a coactiavtor for Swi6p 
As discussed in the preceding section (The role of TFIID in the regulation of 
transcription initiation: Role of TFIID as coactivator), a pressing question in the field 
of gene transcription is how exactly TFIID stimulates transcription in vivo. To be able to 
answer this question, it is first important to identify transcription factors that likely 
interact with TFIID in vivo.  
In our laboratory, mass spectrometric analyses of proteins associated with TFIID 
that had been immunopurified from yeast identified several transcription factors. One of 
these transcription factors was Swi6p (12). Swi6p was first identified in a screen of 
mutants defective for transcription of the cell-cycle regulated gene, HO (13). Many 
studies since then have illuminated the mode of action of Swi6p, and several aspects of 
Swi6p structure and function are worth mentioning. First, Swi6p is thought to function in 
conjunction with one of two other transcription factors, Swi4p and Mbp1p, forming the 
complexes known as SBF and MBF, respectively. SBF and MBF regulate the expression 
of a group of genes that are expressed at the G1/S phase boundary of the yeast cell cycle. 
SBF and MBF recognize and bind to specific DNA binding sites found in the promoters 
of many of its target genes, CACGAAA and ACGCGTNA, respectively. Swi4p and 
Mbp1p provide the DNA binding specificity, whereas Swi6p does not (14, 15, 16, 17 , 
18). As predicted, Swi6p does not contain any recognizable DNA binding domain. 
However, in reporter gene studies using a series of deletion mutants of Swi6p, an 
activation domain was identified both in the N-terminal and the C-terminal halves of the 
protein (19). These two activation domains are separated by a putative leucine zipper and 
four to five ankyrin repeats; both of these domains are known to function as protein-
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 protein interaction domains in other proteins (19, 20). Finally, Swi6p has been shown to 
interact with Swi4p and Mbp1p via its C-terminus (21) (Figure I-8).  
The role of Swi6p in regulating gene transcription, however, is still not well 
understood. Studies in swi6Δ mutant yeast show that the expression of many SBF and 
MBF target genes, other than HO, is not significantly impaired, if at all, in asynchronous 
cultures of yeast (13, 17, 22, 23, 24). However, in synchronized cultures of swi6Δ yeast, 
the characteristic peak of expression of these target genes at the G1/S phase boundary was 
abolished, resulting in a near steady state level of gene expression throughout the yeast 
cell cycle (23). In conclusion, Swi6p appears to function in activating gene transcription 
in a specific cellular context, the G1/S phase transition of the yeast cell cycle. Consistent 
with this view is the fact that the intracellular location of Swi6p is regulated as a function 
of the cell cycle: during G2 and mitosis, Swi6p is predominantly cytoplasmic but 
becomes nuclear in G1 (25).  
At present, however, the molecular mechanisms by which Swi6p activates gene 
transcription are not understood. Does Swi6p regulate transcription by relieving the 
repressive effects of chromatin or by upregulating levels of transcription initiation or 
both? Therefore, does Swi6p regulate transcription by recruiting chromatin remodeling 
complexes or GTFs or both?  
 
TFIID and cell-cycle regulation 
Previous work has strongly suggested that TFIID plays a role in regulating the 
expression of genes at the G1/S phase transition. Studies using a temperature sensitive (ts) 
allele of one of the yeast TafIIs, TAF1, demonstrated that TAF1 regulates the G1/S phase  
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Figure I-8. Domain map of Swi6p. Shown is a diagram depicting the functional and 
structural domains contained within Swi6p. 
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 transition of the yeast cell cycle, since taf1 ts mutant yeast incubated at the restrictive 
temperature showed a uniform cell cycle arrest in G1 (26). This observation was 
correlated with the fact that the expression levels of several SBF and MBF target genes 
were severely impaired in mutant yeast at the restrictive temperature (10). In addition, the 
stimulation of expression of these genes at the G1/S phase transition was all but abolished 
in synchronized mutant yeast at the restrictive temperature (10).  
Second, analogous studies in mammalian cells pointed to a conserved role of 
TFIID in the regulation of expression of cell cycle genes in metazoans. Hamster cells 
harboring a ts allele of human TAF1 also arrested in G1 at the restrictive temperature (27). 
Furthermore, the expression of several cell cycle regulated genes was impaired at the 
restrictive temperature in this mutant. This defect was shown to be at the transcriptional 
level, as indicated by the results of nuclear run-on assays (28).  
 
A specific role for Taf9p as coactivator for Swi6p 
 As discussed above, there is compelling data that shows that TFIID has a role in 
the expression of a group of genes at the G1/S phase transition of the cell cycle. In 
addition, studies using a ts allele of a yeast TafII, yeast Taf9p, demonstrated a synthetic 
growth defect at the permissive temperature between TAF9 and SWI6 (18). This mutation 
in TAF9 is a single point mutation that converts a tryptophan codon to a premature stop 
codon that would result in the translation of a truncated protein missing 25 amino acids 
from the C terminus (henceforth, this mutation will be referred to as the taf9W133stop 
mutation) (Figure I-9). Furthermore, the peak in expression of two cell-cycle regulated 
genes, PCL2 and CLB5, was reduced in G1 at the permissive temperature in synchronized  
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Figure I-9. Diagram of the protein predicted to be encoded by the taf9W133stop 
mutation.   
(Top) Shown is a diagram of wild-type yeast Taf9p, and  
(bottom)  mutant Taf9p that may be expressed in yeast harboring the taf9W133stop 
mutation. In the mutant yeast, a single point mutation converts a tryptophan codon into a 
premature stop codon; this mutation is expected to encode a protein that is missing the 25 
amino acids from the C terminus of the wild-type protein. 
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 taf9W133stop yeast. Interestingly, the C terminus of yeast Taf9p has been conserved in 
metazoans (Figure I-10).  
In addition, in our laboratory, it was found that Swi6p could interact with a subset 
of TafIIs (Taf8p, Taf12p, and Taf7p) in wild-type yeast whole cell extracts, and that this 
interaction was disrupted in yeast harboring the taf9W133stop mutation (12) (Figure I-
11). 
Taken together, the observations discussed in the preceding two sections support a 
model in which TFIID stimulates transcription of a group of genes at the G1/S phase 
transition by serving as a coactivator for Swi6p via direct, mutationally sensitive  
interactions between Swi6p and Taf9p. 
 
Hypothesis and specific aims 
I hypothesize that TFIID serves as a coactivator for Swi6p at the promoters of 
Swi6p-regulated genes. Because of the genetic and biochemical data that suggests an 
interaction between Swi6p and Taf9p, I also hypothesize that Taf9p plays an important 
role in mediating the coactivator function of TFIID for Swi6p.  
My original specific aims had centered on the role of Taf9p. My original aims 
were as follows: 
1) characterize the mode of interaction of Taf9p with SBF and MBF; 
2) (investigate the) role of Taf9p in regulating PCL2 transcription at Start; and 
3) characterize interaction of SBF and MBF with Taf9p at endogenous PCL2 and 
CLB5 promoters. 
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 During the course of this research, attention shifted away from Taf9p as a result 
of the variability observed in the taf9W133stop mutant and from the lack of evidence 
supporting a direct interaction between Taf9p and SBF (discussed in Chapter III and 
Chapter II, respectively).  
Therefore, I modified my original specific aims to the following: 
1) characterize the interaction of Swi6p/SBF with TFIID, and  
2) characterize the interaction of Swi6p/SBF with TFIID at promoters of co- 
regulated genes in vivo.  
For the first specific aim, I characterized further the interaction between Swi6p 
and the TFIID complex through co-immunoprecipitation analyses of Swi6p with various 
TafIIs in wild-type yeast and yeast harboring the taf9W133stop mutation. These 
experiments are discussed in Chapter III. I also identified the subunit(s) of TFIID that 
mediate interaction with Swi6p through Far Western analyses of interaction between 
TFIID subunits and SBF. The Far Western analyses are discussed in Chapter II.  
 For the second specific aim, I performed Northern blot analyses of gene 
expression in taf12 temperature sensitive mutant yeast and in swi6Δ yeast. These 
experiments are discussed in Chapter II.  
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Figure I-10.  
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 Figure I-10. The C terminus of Saccharomyces cerevisiae Taf9p is conserved across 
several metazoan species. Shown are the amino acid alignments of Taf9p from two 
species of yeast and several metazoan species. The sequences were aligned in 
MacVector. The sequences are numbered according to the Taf9p sequence from S. 
cerevisiae. Beneath the sequences is a suggested consensus sequence.  
S. cerevisiae = Saccharomyces cerevisiae; H. sapiens = Homo sapiens; M. musculus = 
Mus musculus; R. norvegicus = Rattus norvegicus; C. elegans = Caenorhabditis elegans; 
S. pombe = Schizosacchromyces pombe; D. melanogaster = Drosophila melanogaster.
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Figure I-11. In taf9W133stop yeast, the co-immunoprecipitation of Swi6p with three 
TafIIs was impaired. Portions of whole cell extract (WCE) were immunoprecipitated 
with polyclonal antibodies against Taf8p, Taf12p, or Taf7p. The proteins detected in the 
immunoprecipitate by immunoblot are indicated at the left. Swi6p co-immuonprecipitated 
with Taf8p, Taf12p and Taf7p in wild-type yeast but this interaction was impaired in 
taf9W133stop yeast. “TAF9” and “tafW133stop” refer to yeast strains that are wild-type 
and mutant, respectively. 
C = control immunoprecipitation. 
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 CHAPTER II 
 
IDENTIFYING TFIID SUBUNITS AS CANDIDATES FOR PROVIDING 
COACTIVATOR FUNCTION FOR SWI6P 
 
 
The first, and most critical, criterion for demonstrating that TFIID is a coactivator 
for Swi6p is that TFIID must interact directly with Swi6p. Since Swi6p functions in vivo 
as part of the SBF and MBF complexes, I decided to examine interaction between TFIID 
and Swi6p in the context of these complexes. For sake of simplicity and availability of 
reagents, I decided to focus on one of these complexes, SBF. Initial studies of TFIID 
coactivator function in vitro had shown that transcription factors activated transcription 
through direct interaction with only a subset of TafIIs (1, 5, 7). Furthermore, mutations in 
transcription factors that impaired interaction with these TafIIs also impaired 
transcriptional activation in vitro. Therefore, I hypothesized that SBF may also activate 
transcription through only a subset of TafIIs. I performed Far Western analyses to answer 
two questions simultaneously: does SBF interact with TFIID in vitro, and if so, does SBF 
interact with only a subset of TafIIs?  
 I found that SBF did interact in vitro selectively with a subset of TafIIs (Taf12p, 
Taf4p, and Taf5p). With this information, I performed Northern blot analyses in 
asynchronous cultures of swi6Δ and a temperature sensitive (ts) mutant of TAF12 to 
identify a gene(s) that is (are) co-regulated by Swi6p and TFIID. I found that several cell-
cycle regulated genes are regulated by TAF12 in asynchronous yeast, but none of these 
genes were regulated by SWI6 in asynchronous yeast.  
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 Materials and Methods 
 
In vitro studies of protein-protein interaction 
 Production of anti-Swi6p antibodies. I cloned DNA encoding the C  
terminal half of Swi6p into a pET19b expression vector. The DNA had been generated by 
PCR of genomic yeast DNA (Invitrogen) using primers specific for the coding region of 
that portion of SWI6. See Table II-1 for the sequences of the primers used in the PCR. 
The cloned vectors were transformed into a DH5α E. coli strain. The plasmids were 
purified and the inserts were sequenced. The plasmids were then transformed into BL21 
pLysS and BL21 Codon plus E. coli strains.  
The pET19b expression vector adds an N terminal His10 tag to the insert. 
Therefore, the C terminal Swi6p fragment was purified by a one-time pass of bacterial 
lysate on a Ni2+NTA column under denaturing conditions, and the bound protein was 
eluted with increasing concentrations of imidazole (Figure II-1). Upon renaturation by 
dialysis, about 50% of the protein precipitated. The soluble protein was sent to Bethyl 
Laboratories, where it was used to immunize rabbits. The remaining insoluble protein 
was re-solubilized with a non-detergent sulfobetaine (NDSB 201). The re-solubilized 
protein was covalently cross-linked to cyanogen bromide (CNBr)-activated sepharose. 
Ten mL of serum from immunized rabbits were filtered through a 0.8μM membrane. 
Antibodies were purified from the filtered serum as follows: the serum was incubated 
with the antigen cross-linked to CNBr-activated sepharose, unbound antibody was 
washed from the resin with an increasing NaCl concentration gradient, and the Swi6p-
antibodies bound to the resin were eluted with 0.1M Na citrate, pH 2.8. The eluates were  
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 Table II-1. Details on cloning the C terminal half of Swi6p.  
(Top) Sequences of primers used in PCR of an insert encoding the C terminal fragment of 
Swi6p. The locus ID for SWI6 was obtained from the online Saccharomyces Genome 
Database. 
(Bottom) The sequence of the multiple cloning site in the pET19b vector (Novagen). 
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Figure II-1. The C terminal half of Swi6p was successfully expressed in E. coli. A 
Coomassie stain of the purification of a His10-tagged, C terminal fragment of Swi6p. 
Lanes designated as “XmM” refer to imidazole concentrations. The numbers to the right 
of the gel are the MWs, in kDa. 
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 collected in 600 μL fractions in chilled 1.5mL-eppendorf tubes containing 60 μL of 1M 
Tris acetate pH 9.0; the pH of the eluates was verified to be a pH of 7 with pH paper.  
The optimal dilution of anti-Swi6p for detection purposes was determined by 
probing increasing amounts of the recombinant, His10-tagged C terminal fragment of 
Swi6p immobilized on a 0.45 μM PVDF membrane with different dilutions of anti-
Swi6p. The specificity of anti-Swi6p was determined by probing yeast WCEs from the 
strains indicated in Table II-2 (Figure II-2).  
Far Western assay. 20X Transfer buffer consisted of the following per  
liter of buffer: 81.6 g bicine; 104.8 g bis-Tris; 6.0 g EDTA; and 0.2g chlorobutanol. 
Binding buffer consisted of the following: 20mM HEPES-KOH pH 7.6; 75mM KCl; 
2.5mM MgCl2; 0.1mM EDTA; and 0.05% (v/v) NP-40. TBS-T consists of the following: 
25mM Tris-HCl pH 7.6; 150mM NaCl; and 0.05% Tween-20 (v/v). 
See Figure II-3 for a basic schematic of a Far Western assay. A purified yeast 
TFIID preparation that contained a TAP-tagged Taf1p was loaded in two lanes on a 4-
12% bis-Tris gel separated by a lane containing prestained Benchmark MW markers 
(Invitrogen). TFIID subunits were separated by SDS-PAGE. The proteins were 
electroblotted onto a 0.45 μM PVDF membrane for two hours in 1x transfer buffer/10% 
methanol (v/v). One lane of TFIID was stained with 0.05% (w/v) Coomassie R-250, 
whereas the adjacent lane of TFIID was further subjected to Far Western analyses. In 
some experiments, recombinant His6-tagged TafIIs were  
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Table II-2. Yeast strains used to test polyclonal anti-Swi6p. 
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Figure II-2. The polyclonal antibodies raised against the C terminal half of 
recombinant Swi6p specifically detect yeast Swi6p. 
 a. Shown are the results of an immunoblot in which WCEs prepared from wild-type 
yeast and yeast that express HA3 or myc18-tagged Swi6p were probed with polyclonal 
anti-Swi6p.  
b. Shown are the results of a separate immunoblot in which WCEs prepared from wild-
type yeast and swi6Δ yeast were probed with polyclonal anti-Swi6p.  
In a. and b., the top most band seen in the figure is Swi6p (either untagged or tagged with 
HA3 or myc18 epitopes). The numbers to the left of the immunoblot in a. and the numbers 
to the right of the immunoblot in b. are the MWs, in kDa. 
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Figure II-3. 
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 Figure II-3. Schematic of a Far Western assay. First, yeast TFIID was subjected to 
SDS-PAGE. Proteins were then electroblotted onto a PVDF membrane, and renatured 
during blocking in 1%BSA/binding buffer/1mM DTT. The membrane was then 
incubated with soluble, recombinant SBF. Unbound SBF was washed away, and bound 
SBF was detected with polyclonal anti-Swi6p antibodies in a standard immunoblot. 
HRP = horseradish peroxidase.
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 electrophoresed on the same gel as yeast TFIID. The amount of recombinant TafII loaded 
was equal to the amount of the corresponding TafII in the portion of yeast TFIID that was 
loaded on the gel and subjected to Far Western analysis. The membrane was blocked for 
one to two hours in binding buffer with 1% BSA/binding buffer/1mM DTT at either 
room temperature or in the cold room, and then probed with SBF, which had been 
purified from baculovirus-infected insect cells, for 14-21 hours.  The membrane was 
rinsed once with 1%BSA/binding buffer/1mMDTT, and then rinsed three times with 
binding buffer/1mM DTT only. The membrane was then subjected to Western blot as 
follows: the membrane was incubated with purified anti-Swi6p, diluted 1:5000 in 1% 
nonfat milk/TBS-T, either overnight in the cold room or for several hours at room 
temperature. The membrane was then rinsed once with 1% nonfat milk/TBS-T followed 
by three rinses with TBS-T only. The membrane was incubated with goat anti-rabbit Fc 
cross-linked to HRP for 30 minutes, and the membrane was then washed as described 
above. Bound SBF was visualized on the membrane by enhanced chemiluminescence 
(Roche). The images were detected by exposure to Kodak BioMax film. TFIID subunits 
that bound SBF were identified by aligning the Coomassie-stained strip of TFIID with 
the bands seen on the film. The positions of the prestained MW markers were used as 
reference points for the alignment. 
The recombinant SBF used in this analysis was purified as untagged proteins by a 
member of our laboratory, Krassimira A. Garbett. The components of SBF, Swi4p and 
Swi6p, were expressed simultaneously by separate baculovirus vectors in insect S2 cells. 
The baculovirus vectors had been obtained from the lab of Brenda Andrews. I probed 
purified SBF with my polyclonal anti-Swi6p, and showed that the antibodies detected 
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 Swi6p and not Swi4p (Figure II-4). The TAP-TFIID used in these studies was purified by 
another member of our laboratory, Manish K. Tripathi. Nearly all the recombinant His6-
TafIIs used in this study had been purified by Steven Sanders, except for His6-Taf4p, 
which had been purified by Belgin Cenkci. Each recombinant His6-TafII had been 
separately expressed as a His6-tagged protein in E. coli or in baculovirus-infected insect 
cells (Figure II-5).  
Far Western competition assay. This assay was performed as described  
above (see Far Western assay) except that a 2.5 to 10 fold molar excess of recombinant 
His6-Taf12p or His6-Taf6p was incubated simultaneously with SBF (Figure II-6). In one 
set of competition experiments, His6-Taf12p or His6-Taf6p was tested for their ability to 
compete with yeast TFIID immobilized on the membrane for binding to SBF. In another 
set of experiments, His6-Taf12p or His6-Taf6p was tested for their ability to compete with 
recombinant His6-Taf12p immobilized on the membrane for binding to SBF. “Molar 
excess” refers to multiples of the pmol of Taf12p or of Taf6p that are in 1.62 μg of yeast 
TFIID, which was the amount of TFIID loaded on the gel and subjected to Far Western 
analysis. 
 
In vivo studies of TafII regulation of cell-cycle regulated genes 
See table II-3 for yeast strains used in this analysis. 
Temperature shift assay. A taf12 temperature sensitive (ts) strain and its  
cognate wild-type (strains YSB547 and YSB452, respectively) were subjected to a 
temperature shift experiment. For each strain, the following was performed: yeast were 
streaked onto the appropriate  
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Figure II-4. Polyclonal anti-Swi6p detects Swi6p, not Swi4p, in purified, 
recombinant SBF that had been expressed in baculovirus-infected insect cells.  
(Top) Coomassie-stained gel of recombinant SBF. From left to right, SBF was loaded in 
increasing amounts across two lanes.  
(Bottom) Anti-Swi6p immunoblot of the same batch of SBF that is shown in the 
Coomassie-stained gel.  
In both top and bottom panels, the numbers to the left of the gel or immunoblot are the 
MWs, in kDa. 
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Figure II-5. Sypro Ruby-stained gels of each recombinant His6-TFIID subunit, 
except Taf8p. The numbers to the right of each gel are the MWs, in kDa. In the top gel, 
each recombinant TFIID subunit was loaded onto the gel in decreasing amounts (left to 
right) over two or three lanes. In the bottom gel, each recombinant TFIID subunit was 
loaded onto the gel in increasing amounts (left to right) over three lanes. The arrows 
indicate the position of each full-length recombinant TFIID subunit.  
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Figure II-6. Schematic of a Far Western competition assay. The experiment is as 
described in Figure II-3, except that either His6-Taf12p or His6-Taf6p was incubated 
simultaneously with SBF. 
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drop-out synthetic media plate from frozen lab glycerol stocks and incubated at 30°C for 
two days. A 50 mL starter culture was prepared in YPAD and inoculated with a single 
colony from the plate culture. Starter cultures were incubated, with shaking in an open-air 
incubator, at room temperature until the starter cultures were saturated. Six hundred ml of 
YPAD was inoculated with a volume of starter culture so that the starting OD600/mL was 
0.125. The culture was incubated with shaking in an air incubator at 30°C. The growth of 
the culture was monitored by OD600 and by cell counting in a hemocytometer. When the 
culture reached an average cell density of two to four million cells per ml, two 50mL 
aliquots were harvested as follows: cells from each aliquot were collected by vacuum 
filtration onto a 5.0µm polycarbonate membrane (Millipore), washed once with 25 mL of 
cold sterile water, and flash frozen on dry ice in pre-chilled 15mL-conical tubes. The 
frozen cells were then stored at -80°C. In addition, one ml was taken from each culture to 
perform a temperature shift plate assay (see below). The remaining culture was harvested 
by vacuum filtration on a 1.0 µm mixed cellulose ester membrane and washed once with 
50 mL of cold sterile water.  The cells were eluted from the membrane by shaking in a 
50ml aliquot of pre-warmed YPAD in a 37°C air incubator for five minutes. The 
membrane was discarded and the 50 mL of suspended cells were added to a pre-warmed 
aliquot of 500 mL of YPAD, thus bringing the total volume of the culture to 550 mL.  
The culture was then incubated, with shaking, in the 37°C air incubator; the 
culture was removed from the air incubator to room temperature briefly at 30 minutes and 
60 minutes incubation to collect two 50mL aliquots of culture in 50mL-conical tubes 
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 (Falcon). These aliquots were harvested and stored at -80°C, as described in the 
preceding paragraph.  
 Plate assay for temperature sensitivity. Fifty μL of the one mL aliquot  
harvested previously (see Temperature shift assay), was plated onto each of two YPAD 
plates. One plate was incubated at 30°C whereas the other was incubated at 37°C. Plates 
were examined one day later (Figure II-7). 
Growing and harvesting swi6Δ yeast. Cultures of a swi6Δ strain and its  
cognate wild-type strain (BY4741) were grown and harvested at the permissive 
temperature only.  For each strain, the following was performed: yeast were streaked onto 
YPAD plates from frozen lab glycerol stocks and incubated at 30°C for two days. A 
7.5mL starter culture was prepared in YPAD and inoculated with a single colony from 
the plate culture. Starter cultures were incubated, with shaking in a 30°C incubator, until 
the starter cultures were saturated. Two hundred and fifty ml of YPAD was inoculated 
with a volume of starter culture so that the starting OD600/mL was 0.125. The culture was 
incubated with shaking at 30°C. The growth of the culture was monitored by OD600 and 
by cell counting in a hemocytometer. When the culture reached an average cell density of 
two to four million cells per ml, two 50mL aliquots were harvested as follows: cells from 
each aliquot were collected by vacuum filtration onto a 5.0µm polycarbonate membrane 
(Millipore), washed once with 25 mL of cold sterile water, and flash frozen on dry ice in 
pre-chilled 15mL-conical tubes. 
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Table II-3. Yeast strains used in Northern blotting studies. 
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Figure II-7. Plate assay confirming the temperature sensitivity of the taf12 
temperature sensitive yeast strain.  Shown is the result of the plate assay of the taf12 ts 
strain (YSB547, taf12 in figure) and its cognate wild-type (YSB452, TAF12 in figure). 
Across the top are the temperatures at which the plates had been incubated. 
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RNA isolation.  TE consisted of 10mM Tris-HCl pH 8.0 and 1mM EDTA pH 8.0, 
whereas T0.1E consisted of 10mM Tris-HCl pH 8.0 and 0.1mM EDTA pH 8.0 
RNA was isolated from each 50mL aliquot harvested previously (see 
Temperature shift assay and Growing and harvesting swi6Δ yeast) as follows: 1.5mL of 
acid saturated phenol:chloroform (125:5:1 phenol:CHCl3:isoamyl alcohol, equilibrated to 
pH 4.7, Sigma) was added directly to each membrane in the 15mL collection tube. Most 
of the cells were eluted from the membrane with vigorous vortexing. Then, 1.5mL of 
TE+0.5%SDS (w/v) was added to the membrane, and the remainder of the cells was 
eluted with vigorous vortexing. The aqueous phase was separated with centrifugation in a 
Beckman Coulter centrifuge for five minutes at 4°C. About one mL of aqueous phase 
was recovered, which was divided between two 1.5mL-eppendorf tubes. Five hundred μL 
of acid saturated phenol was added to each aqueous phase. RNA was isolated by hot 
phenol extraction as follows: the aqueous phase was vortexed for ten seconds, incubated 
in a 65°C water bath for ten minutes, and spun in a microfuge at room temperature for 
three minutes at 14krpm. The cycle of vortexing, incubation, and spinning was repeated 
for a total of six times.  
The aqueous phase was transferred to a new 1.5mL-eppendorf tube after the last 
cycle, and then extracted once with acid saturated phenol and twice with choloroform. 
RNA was precipitated overnight from the aqueous phase at -80°C in one-eighth the 
volume of Na acetate pH 5.2 and twice the volume of cold 100% ethanol (these volumes 
are relative to the volume of the final aqueous phase obtained after extraction, which was 
typically 400 µL). The RNA pellet was recovered by spinning for 25 minutes in a 
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 microfuge at top speed in the cold room. The pellet was then washed once with cold 80% 
ethanol, and air-dried for one hour. The pellet was then dissolved in fifty μL of 
T0.1E+0.1%SDS (w/v) for 30 to 40 minutes in a 65°C water bath.  
Radioactively labeling probes for Northern blot.  The probe for each gene  
examined was generated by PCR of yeast genomic DNA (Invitrogen) using a pair of 
gene-specific primers. See table II-4 for the sequences of the primers that were used to 
amplify each gene. Each reaction consisted of the following components: 1X PCR buffer 
II (Applied Biosystems); 1.5mM MgCl2; 0.25µM forward primer; 0.25μM reverse 
primer; 0.2mM dNTPs; 8pg/µL yeast genomic DNA (Invitrogen); and Taq polymerase 
(made in our laboratory). The reaction conditions were the following: initial denaturation 
step for three minutes at 95ºC; 30 cycles of denaturation, annealing, and product 
extension; and a terminal extension step for five minutes at 72°C. Each cycle consisted of 
the following: denaturation for 30 seconds at 95ºC, annealing for one minute, and product 
extension for two minutes at 72°C. The annealing temperature varied for each primer 
pair; optimal annealing temperatures had been determined empirically for each primer 
pair. PCR was carried out using the BioRad iCycler. Each probe was purified by gel 
elution and phenol:CHCl3 extraction from 16 PCR reactions, and quantitated by EthBr (1 
μg/mL) staining of PCR product electrophoresed on a 1.2% agarose gel.  
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 Table II-4. Sequences of primers used to amplify mRNAs of genes analyzed by 
Northern blot. The locus ID for each gene was obtained from the online Saccharomyces 
Genome Database. bp = base pairs. 
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 The PCR-generated probes were labeled with α32P-dCTP by the Klenow fragment of 
DNA polymerase I. Each reaction consisted of the following components: 25ng of  
probe; 1x labeling buffer (10x labeling buffer from New England Biolabs); 20 μM each 
of dGTP, dCTP and dTTP (100 mM stocks from New England Biolabs); 2.5 µL of α32P-
dCTP (6000 Ci/mMol); one µL of Klenow fragment of DNA polymerase I (New England 
Biolabs);  and nuclease-free water (Promega) to bring the final volume of the reaction to 
50µL. The reactions were incubated at room temperature from five to seven hours. The 
reaction was terminated with addition of five µL of 0.5M EDTA pH8.0. Each reaction 
was purified by passing the reaction over a Sepahdex G-50 column. Each labeled probe 
was eluted with 300 μL of TE pH 8.0. Three hundred and fifty μL of each eluate was 
recovered and stored in the refrigerator overnight before use.  
Northern blots. Denaturation mix consisted of the following: 66% (v/v)  
deionized formamide; 1.3x MOPS running buffer; and 8% formaldehyde. A 
formaldehyde-agarose gel consisted of the following: 0.6M formaldehyde; 1.5% agarose; 
and 1X MOPS running buffer. 10X MOPS running buffer consisted of the following: 
0.2M MOPS; 50mM Na acetate; and 10mM Na2EDTA. The pH of the buffer was 
adjusted to a pH of 7.0.  20X SSPE consisted of the following: 3.6M NaCl; 0.2M 
NaH2PO4; and 20mM NaEDTA. The pH of the buffer was adjusted to a pH of 7.2-7.4. 
Therefore, 5X SSPE was a 1:4 dilution of 20X SSPE in sterile water. 
Hybridization solution consisted of the following: 5X SSPE; 5X Denhardt’s 
solution; 0.1% (w/v) SDS; 50% (v/v) deionized formamide; and 30 μg/mL sonicated 
salmon sperm DNA. (5X Denhardt’s solution was made according to the composition 
described in Molecular Cloning: A Laboratory Manual by Maniatis et al). Right before 
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 adding the salmon sperm DNA, the DNA was heated in boiling H2O for 7.5 minutes, 
chilled on ice for five to 7.5 minutes, and spun brielfy at 12krpm in the cold room to 
recover the condensate.  
 Concentrations of isolated RNA were determined by measuring A260 of duplicate 
samples. A sample for measurement consisted of either 2.5 µL or 1.3 µL of RNA diluted 
in 500 µL of nuclease-free water.  A260 measurements of all samples were either 0.6 or 
less. Two hundred and twenty µg of RNA was then dissolved in denaturation mix to a 
final volume of 275 µL, heated in a 65◦C water bath for 10 minutes, chilled on ice for 10 
minutes, and spun briefly in the cold room to recover condensate. Twenty μg of each 
RNA was loaded onto a formaldehyde-agarose gel and electrophoresed for two to 2.5 
hours at 120V in 1X MOPS running buffer. The gel was then rinsed in sterile water three 
times, 20 minutes per rinse. The gel, Hybond-N membrane (Amersham Biosciences), and 
filter papers were then incubated in 20X SSPE for 30 minutes. RNA was blotted onto the 
membrane in 20X SSPE for 12-14 hours by upward capillary transfer. Following transfer, 
the membrane was rinsed in 5X SSPE for 30 minutes and air-dried. The RNA was 
crosslinked to the membrane by UV (Auto function, UV Stratalinker 2400, 1200J). The 
membrane was then stained with 0.02%methylene blue/0.3M Na acetate pH 5.2, and 
scanned with a regular light scanner.  
In parallel with the gel used in membrane transfer, another formaldehyde-agarose 
gel was loaded with RNA and electrophoresed as described above. Instead of undergoing 
membrane transfer, however, this gel was rinsed overnight with sterile water, stained 
with EthBr (1 μg/mL) for 30 minutes, rinsed with sterile water, and photographed under 
UV (Figure II-8).  
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Figure II-8. The integrity of isolated RNA was determined by EthBr staining. RNA 
was isolated from different strains incubated at the permissive temperature (0’) and at 
various times at the restrictive temperature (30’, 60’). The (‘) symbol indicates minutes. 
TAF12 = cognate strain of taf12 ts strain; taf12 = taf12 ts strain. The numbers to the left 
are the sizes of the RNA markers, in base pairs. 
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 Each membrane was incubated in 10 mL of hybridization solution for two and a 
half hours at 42°C. Right before adding to the hybridization solution, the radioactively 
labeled probe was heated in boiling H2O for five minutes, chilled on ice for five minutes, 
and spun for 30 seconds at 12krpm in a microfuge in the cold room. Three hundred and 
fifty μL of radioactively labeled probe was added to the hybridization solution, and the 
membrane was incubated with probe for 21 hours in a 42°C hybridization oven. The 
temperature control was then turned off. When the oven temperature reached about 30°C, 
the membrane was washed twice with 2X SSPE/0.5%SDS (w/v) and then twice with 
0.2X SSPE/0.5%SDS (w/v). The membrane incubated in the last wash solution as the 
oven temperature was brought back up to 42°C, and then the membrane was washed 
again twice with 0.2X SSPE/0.5%SDS. Temperature control was turned off, and the 
membrane was rinsed finally with 2X SSPE. In each wash, the membrane had been 
washed with 25 mL of wash buffer for 15 minutes, except for the last rinse, which had 
been for five minutes. The membrane was air-dried, enclosed in Saran Wrap plastic film, 
and exposed to a phosphorimaging K screen. The signals from the K screen were 
detected with an FX imager, and analyzed using Quantity One software.  
 
 Results  
 
In vitro studies of protein-protein interaction 
Far Western analyses of binding between yeast TFIID and SBF showed that SBF 
does indeed interact directly with a subset of TafIIs in vitro (Figure II-9a). SBF interacted 
most strongly with Taf12p/Taf8p, with weaker binding to Taf5p/Taf7p, Taf1p, and to 
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 Taf4p. Unexpectedly, interaction with Taf9p was not detected. Due to gel resolution, 
Taf5p and Taf7p co-migrated as did Taf12p and Taf8p, so it was not clear from these 
results alone which TafII out of each pair was interacting directly with SBF.  
As negative controls, experiments were performed in which either SBF or anti-
Swi6p was omitted during the procedure (Figure II-9b). These controls verify that the 
interaction between SBF and the subset of yeast TafIIs is real, rather than an artifact of 
interaction between TFIID and either the primary or secondary antibody. 
 Far Western analysis of SBF binding to all recombinant TafIIs revealed results 
similar to those for TFIID purified from yeast (Figure II-10). SBF interacted with His6-
Taf12p, and also with His6-Taf5p and His6-Taf4p. However, no interaction between SBF 
and His6-Taf1p and His6-Taf7p was observed. Furthermore, the recombinant forms of 
those yeast TFIID subunits that did not interact with SBF (which includes Taf9p) also did 
not interact with SBF.  
SBF probably does not interact with yeast Taf7p since SBF did not interact with 
His6-Taf7p. Because recombinant Taf8p was unavailable and difficult to purify in 
sufficient quantities, I could not assay for direct interaction between SBF and 
recombinant Taf8p.  However, SBF probably does not directly interact with yeast Taf8p 
since the specific activity of SBF binding to yeast Taf12p/Taf8p was equivalent to SBF 
binding to an amount of His6-Taf12p that was equivalent to the amount of yeast Taf12p 
in the Far Western assay. If SBF also interacted directly with Taf8p, then one would 
expect that the specific activity of binding between SBF and His6-Taf12p would be less 
than binding between SBF and yeast Taf12p/Taf8p. Finally, differences in post-
translational modifications in yeast Taf1p and in His6-Taf1p may explain why SBF was  
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Figure II-9. 
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Figure II-9. SBF interacts in vitro with a subset of TafIIs in yeast TFIID.   
a. Shown is the result of a Far Western assay in which interaction was detected between 
SBF and yeast TFIID. From left to right, increasing amounts of TFIID were probed (0.8 
μg, 1.6 μg, and 3.3 μg).  Bound SBF was detected by polyclonal antibodies against 
Swi6p. To the far left is a Coomassie-stained strip of 2.3 µg of yeast TFIID. 
b. (Far left) Coomassie stain of 2.4 μg of yeast TFIID separated by SDS-PAGE and 
immobilized on PVDF. (Second panel from the left) Interaction was detected between 
SBF and 1.6 μg of yeast TFIID.  (Third and fourth panels from the left) results of the Far 
Western assay with either anti-Swi6p or SBF omitted during the procedure. The second 
through fourth panels also show the results of SBF interaction with recombinant His6-
Taf12p loaded in the lane adjacent to yeast TFIID. 
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Figure II-10.  SBF interacts with recombinant counterparts of most of the TafIIs 
that it interacted with in the context of yeast TFIID. (Far right) Coomassie stain of 
yeast TFIID separated by SDS-PAGE and transferred to PVDF. (All other lanes) Far 
Western analysis of yeast TFIID and of the recombinant counterparts of all the TFIID 
subunits except Taf8p. The arrows indicate the full-length proteins in lanes in which 
more than one band is evident. The numbers across the top of each lane correspond to the 
various TafIIs (1 = Taf1p; 2 = Taf2p, etc.) 
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 able to interact with yeast Taf1p but not with the recombinant Taf1p, although the 
amount of His6- Taf1p in these assays was equivalent to the amount of Taf1p in yeast 
TFIID. The observation that SBF bound to both the yeast and recombinant versions of a 
subset of TafIIs suggests that the interaction between SBF and these TafIIs is mediated by 
the primary amino acid sequence of these TafIIs independent of any post-translational 
modifications.   
The specificity of the interaction between SBF and the TafIIs was determined 
through a series of competition assays. First, I demonstrated that a ten molar excess of 
recombinant His6-Taf12p in solution could block interaction between SBF and the subset 
of interacting yeast TafIIs (Taf12p, Taf4p, Taf1p, and Taf5p) identified previously 
(compare Figure II-9 and Figure II-10 with Figure II-11a). His6-Taf12p could also block 
interaction between SBF and recombinant His6-Taf12p that was immobilized on the 
membrane.  
As a negative control, competition experiments were also performed with His6-
Taf6p; Taf6p had been shown not to interact with SBF in previous experiments (Figure 
II-9 and Figure II-10). A ten fold molar excess of His6-Taf6p did not significantly impair 
interaction between SBF and His6-Taf12p immobilized on the membrane (Figure II-11a). 
Also, binding between SBF and yeast Taf4p or yeast Taf1p was not significantly 
affected. However, there was some decrease in binding observed between SBF and yeast 
Taf12p immobilized on the membrane. Interestingly, this was accompanied by an 
increase in binding between SBF and yeast Taf5p. Nonetheless, it was obvious that, as a 
competitor, His6-Taf12p was much more effective than His6-Taf6p. 
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 In another set of experiments, recombinant His6-Taf12p in solution blocked SBF 
interaction with recombinant His6-Taf12p bound to the membrane in a linear fashion, 
whereas recombinant His6-Taf6p could not effectively compete with His6-Taf12p bound 
to the membrane for binding to SBF (Figure II-11b).  
Together, both sets of competition experiments indicate that the interaction 
between SBF and the TafIIs  is specific. 
 
 In vivo studies of TafII regulation of cell-cycle regulated genes 
The expression of six cell-cycle regulated genes (CLN2, TOS4, GIC1, HCM1, 
SWE1, and YHP1) was examined by Northern blot in swi6Δ yeast at the permissive 
temperature, and in yeast harboring a ts allele of TAF12 at both the permissive and 
restrictive temperatures (see Table II-5 for more details on these genes).  
I focused further on Taf12p because Taf12p has been implicated as a coactivator 
for the mammalian transcription factor, ATF (29). Furthermore, Taf12p may mediate 
interaction between a yeast transcription factor, Gcn4p, and another coactivator complex, 
SAGA (30). Therefore, Taf12p may play an important role in mediating interaction 
between transcription factors and coactivators in general. 
Expression of all genes was lower or even absent in taf12 ts yeast relative to wild-
type at the permissive temperature (Figure II-12). However, the effects of heat shock may 
not have been well controlled for in this experiment as there were changes in gene 
expression in TAF12 wild-type yeast at the restrictive temperature (data not shown). 
Therefore, no definitive conclusions can be drawn. In future iterations of this experiment, 
controlling the temperature of the yeast cultures with a water bath may be better than 
 60
 incubation in an air incubator for controlling effects of heat shock. Also, the time course 
of incubation at the restrictive temperature should be extended up to two hours, as it takes 
about this long for yeast to recover completely from heat shock. 
  Nonetheless, the observation that expression of all genes in the taf12 yeast was 
significantly lower than in TAF12 yeast at the permissive temperature suggests that 
expression of these genes is impaired in taf12 yeast. Therefore, I conclude that all the 
genes that I tested are likely to be regulated by Taf12p. Interestingly, one of the genes 
identified was CLN2, which had already been shown to be dependent on another TFIID 
subunit, Taf1p (10). Furthermore, it has been recently shown by ChIP assay that Swi6p 
associates with the CLN2 gene promoter in a cell cycle-dependent fashion (31).  
I also compared expression of these genes in swi6Δ yeast and its cognate wild-
type at the permissive temperature.  I did not detect reduction in expression of any of the 
genes in swi6Δ yeast relative to wild-type (Figure II-13); some genes were even 
expressed at a higher level in swi6Δ relative to wild-type. In studying the literature, these 
results are not surprising. Other than the HO gene, the expression of several putative 
SBF-target genes showed only modest reduction, if at all, in asynchronous swi6Δ cultures 
(17, 22, 23, 24).  
One possible mechanism for this modest effect is that Swi6p may play a limited 
role in gene expression in that it simply modulates the periodicity of gene expression but 
is not absolutely required for gene expression. Indeed, studies have shown that, in 
synchronized cultures of swi6Δ yeast, either the periodicity of expression of some genes 
is abolished or only the peak level of expression of some genes is dampened without any  
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Figure II-11.
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Figure II-11. Interaction between SBF and TafIIs is specific.  
a. His6-Taf12p competes with yeast TFIID immobilized on PVDF for binding to SBF, 
whereas His6-Taf6p could not compete effectively with immobilized yeast TFIID for 
binding to SBF. On the far right is a Coomassie-stained strip of yeast TFIID.  
b. His6-Taf12p competes with His6-Taf12p immobilized on PVDF for binding to SBF, 
whereas His6-Taf6p could not compete with immobilized His6-Taf12p for binding to 
SBF. 
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 Table II-5. Information on the cell cycle regulated genes that were assayed by  
Northern blot.  
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Figure II-12. Gene expression in a taf12  ts mutant. mRNA levels of selected genes 
were analyzed by Northern blotting, and as shown here, normalized to levels of SCR1. 
Bars have been omitted for those data points for which RNA was not detectable (assume 
a value of zero for those data points). 
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Figure II-13. Gene expression was not downregulated in a swi6Δ mutant relative to 
wild-type.  mRNA levels of selected genes were analyzed by Northern blotting, and as 
shown here, normalized to levels of SCR1.  
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 significant effect on expression itself (23). The net result would be a modest to no 
reduction in expression of otherwise Swi6p-regulated genes in asynchronous swi6Δ 
cultures.  
Therefore, analysis of gene expression in synchronized cultures of swi6Δ yeast 
may be necessary to uncover a dependence on Swi6p. 
 
Discussion 
As discussed in the Introduction (Chapter I), one of the pressing questions in the 
field of TFIID biology is how exactly TFIID stimulates gene transcription in vivo. Based 
on experiments performed in vitro, the following model has been proposed: through 
direct, mutationally sensitive interactions with a subset of TFIID subunits, transcription 
factors recruit and/or stabilize TFIID occupancy of the gene promoter. Once localized to 
the promoter, TFIID, through the formation of the PIC, recruits RNA Pol II to the gene 
promoter, resulting in an increase in transcriptional output. 
Through Far Western experiments, I have generated evidence of direct interaction 
between Swi6p and TFIID, specifically between SBF and a specific subset of TafIIs 
(Taf12p, Taf4p, and Taf5p). In addition, through Northern blotting studies, I have 
generated evidence that one of these interacting TafIIs, Taf12p, regulates expression of 
some putative Swi6p-target genes.  
At this point, the data I have generated are consistent with a model in which Swi6p 
stimulates gene transcription by recruiting TFIID to the gene promoter through direct 
interactions between SBF and a subset of TafIIs (Figure II-14). 
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 One caveat of the Far Western assays is that it is not known which component of 
SBF, Swi6p or Swi4p, mediates direct interaction between the TafIIs and SBF. Three 
scenarios can be envisioned: first, Swi6p mediates direct interaction between SBF and the 
TafIIs; second, Swi4p mediates direct interaction between SBF and the TafIIs; or, third, 
both Swi6p and Swi4p mediate direct interaction between SBF and the TafIIs (Figure II-
15a). However, it is also possible that, during the course of the experiment, SBF 
dissociates into its constituent subunits, Swi6p and Swi4p. Swi6p and Swi4p then each 
interact separately with either a redundant or separate subset of TFIID subunits (Figure 
II-15b).  
Several questions regarding interaction between SBF and TFIID need to be 
answered. What is the form of Swi6p that is mediating interaction with Taf12p, Taf4p, 
and Taf5p? In other words, is it the intact SBF complex or Swi6p alone that is mediating 
interaction with these TafIIs? Does Swi4p make any contacts on its own with other TafIIs 
that were not detected in the Far Western assays (for example, Taf9p)? Do SBF and/or 
Swi6p interact with the intact TFIID complex? Preliminary results from a cryo electron 
microscopy (EM) analysis of interaction between SBF and TFIID indicate that interaction  
occurs between intact SBF and TFIID complexes (unpublished communications with 
collaborator, Patrick Schultz). However, it was not determined which subunit (Swi6p or 
Swi4p) mediated direct interaction with TFIID. Intriguingly, SBF contacted a subdomain 
of TFIID which contains Taf12p, Taf4p, Taf5p, and Taf9p.  
The next step is to study TFIID occupancy in vivo on the promoters of Swi6p-
regulated genes in wild-type yeast, and then ultimately, test how promoter occupancy of 
TFIID on these gene promoters is affected in yeast that express mutants of Swi6p that 
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 could not interact with TFIID in vitro. Occupancy of promoters in vivo can be determined 
by chromatin immunoprecipitation (ChIP) analysis. However, one caveat of these studies 
is that any defect in TFIID occupancy may not be attributable, either entirely or in part, to 
defects in interaction with Swi6p alone as other transcription factors also regulate 
transcription of cell-cycle regulated genes. To circumvent this problem, it is suggested 
that TFIID occupancy be measured in synchronized yeast. Since transcription of cell-
cycle regulated genes at the G1/S phase transition is controlled by Swi6p (discussed in 
Results), one can predict that TFIID occupancy of cell-cycle regulated gene promoters in 
G1/S phase will also be regulated by Swi6p. Therefore, one can predict that TFIID 
occupancy of these gene promoters will increase in the G1/S phase transition in parallel 
with an increase in Swi6p occupancy. Finally, the increase in TFIID occupancy at the 
G1/S phase transition would be diminished or abolished in yeast that express mutants of 
Swi6p that could not interact with Taf12p, Taf4p, and Taf5p in vitro.   
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Figure II-14. Model of the mechanism by which TFIID may regulate the expression 
of cell-cycle regulated genes.  
a. SBF (Swi6p and Swi4p heterodimer) binds to the promoters of its target genes in G1 in 
response to G1/S checkpoint signals.  
b.Through direct interactions with a subset of TafIIs, SBF recruits TFIID to the gene 
promoter.  
c. Once at the promoter, TFIID nucleates the formation of the PIC, resulting in an 
increase in transcriptional output.
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Figure II-15. Possible modes of interaction between SBF and TafIIs.  
a. Interaction occurs between SBF and TafIIs. 
  i. Swi6p mediates interaction between SBF and TafIIs. 
 ii. Swi4p mediates interaction between SBF and TafIIs. 
 iii. Both Swi6p and Swi4p mediate interaction between SBF and TafIIs. 
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Figure II-15. Possible modes of interaction between SBF and TafIIs.  
b. During the course of the experiment, SBF dissociates into its constituent subunits, 
Swi6p and Swi4p. Swi6p and Swi4p then each interact with  
 i. a redundant subset of TFIID subunits, or 
 ii. a separate subset of TFIID subunits. 
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 CHAPTER III 
 
INVESTIGATING TAF9P AS A CANDIDATE FOR PROVIDING 
COACTIVATOR FUNCTION FOR SWI6P 
 
 
 
As discussed in the Introduction, studies of yeast harboring the taf9W133stop 
mutation yielded two observations that supported a role for Taf9p as coactivator for 
Swi6p.  First, the taf9W133stop mutation displayed a synthetic growth defect in 
combination with a swi6Δ mutation (18). Second, the association of Swi6p with a subset 
of TafIIs (Taf12p, Taf8p, and Taf7p) in yeast WCE was disrupted in the taf9W133stop 
mutant (12). The simplest interpretation of these observations is that Taf9p mediates 
direct interaction between Swi6p and TFIID. If this were the case, then Taf9p would 
fulfill the first and essential criterion of a coactivator, which is that the coactivator and 
transcription factor must directly interact with each other.  
To test for a direct interaction between TafIIs and Swi6p, I studied interaction in 
vitro between all the TFIID subunits and Swi6p; these experiments are described in detail 
in Chapter II. I also tested for an interaction between TafIIs and Swi6p in vivo through 
co-immunoprecipitation experiments; these experiments are discussed within this 
chapter.  
The initial Swi6p-TFIID co-immunoprecipitation experiments were performed by 
Steven Sanders in our laboratory. Through these experiments, he found that Swi6p co-
immunoprecipitated with some TafIIs (Taf8p, Taf12p, and Taf7p) and that this 
association was disrupted in taf9W133stop yeast (12). These experiments, however, only 
indirectly assay possible interactions between Taf9p and Swi6p in vivo.  Therefore, to 
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 directly study interaction between Taf9p and Swi6p in vivo, I carried out co-
immunoprecipitation experiments in which I immunoprecipitated Taf9p directly and 
probed for Swi6p in the immunoprecipitate. To obtain additional background 
information, I also repeated the initial experiments carried out by Steven Sanders. 
 
Materials and Methods 
 
 Strains used in these studies 
 The taf9W133stop yeast and its cognate wild-type were obtained from the 
laboratory of Brenda Andrews. A member of our laboratory, Steven Sanders, tagged the 
SWI6 allele in each yeast strain with a triple HA epitope at the C terminus. The 21R wild-
type and 21R Taf9p-HA3 strains were obtained from the laboratory of Karsten Melcher. 
Specific details are shown in Table III-1. 
Co-immunoprecipitation analysis in wild-type and taf9W133stop yeast 
Lysis buffer consisted of the following: 20mM HEPES pH 7.9; 10% glycerol 
(v/v); 150mM NaCl; 5mM DTT; 0.1% NP-40; one complete mini-protease inhibitor 
tablets (Roche) in ten mL of buffer; 2mM EGTA; 2mM EDTA; 5mM benzamidine; 2 
μg/mL pepstatin; 5 μg/mL leupeptin; 5 μg/mL aprotinin; 12 μg/mL TPCK; 12 μg/mL 
TLCK; and 0.2 mM PMSF.  Tris buffered saline with Tween-20 (TBS-T) consisted of the 
following: 25mM Tris-HCl pH 7.6; 150mM NaCl; and 0.05% Tween-20 (v/v). 20X 
Transfer buffer consisted of the following per liter of buffer: 81.6 g bicine; 104.8 g bis-
Tris; 6.0 g EDTA; and 0.2g chlorobutanol 
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Table III-1. Yeast strains used in immunoprecipitation studies. Shown is strain 
information for the yeast strains that harbor the taf9W133stop or swi6Δ mutation or that 
express Taf9p-HA3. 
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 Stripping solution consisted of the following: 2% SDS (w/v), 30mM Tris acetate pH 6.7, 
and 100mM β-mercaptoethanol.  
Each strain was grown as follows: yeast were streaked from frozen glycerol 
stocks onto a YPAD plate containing G418 and incubated at 30ºC for two to four days. A 
single colony from the plate culture was inoculated into a starter culture of 7mL 
YPAD/G418 and incubated, with shaking at 250rpm, at 30ºC until the culture became 
saturated.  A starter culture was inoculated into 200 mL of YPAD so that the starting 
OD600/mL was about 0.125 OD600/mL. The 200mL culture was incubated at 30ºC, with 
shaking at 250rpm, until the culture reached an OD600/mL of about 1.3-2.4 OD600/mL. 
Four 50mL-aliquots were collected in 50mL-conical tubes (Falcon) and harvested by 
centrifugation in a Beckman centrifuge for 10 minutes at 4°C. Each pellet was washed 
once with 25 mL of cold sterile water. Each pellet was suspended in one mL of PBS 
(made according to composition in Molecular Cloning: A Laboratory Manual by 
Maniatis et al), transferred to 1.5mL-screw top tubes (Sarstedt) and pelleted by spinning 
for three minutes at 6500 rpm in a microfuge. The supernatant was discarded, the pellet 
was frozen on dry ice, and stored at -70 to -80°C.  
Each yeast cell pellet was thawed in the cold room. Each pellet was beat with a 
mini-bead beater in 600 μL of lysis buffer and 500 μL of glass beads in the cold room. 
The cells were beat for a total of seven cycles, with each cycle consisting of beating for 
1.5 minutes followed by a two-minute incubation on ice. Five μL of each lysate were 
examined under an Olympus microscope, and the lysis efficiency, as determined by 
visual inspection, was over 95%. Four hundred μL of WCE were obtained from each 
lysate by spinning the lysates for ten minutes at 14krpm in the cold room. Each WCE was 
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 pre-cleared with 175 μL of a 1:1 slurry of Protein A sepharose in lysis buffer for five 
minutes on a tiltboard in the cold room. Four hundred and eighty μL of each pre-cleared 
WCE were obtained by spinning for two minutes at 6krpm in the cold room. The protein 
concentration of pre-cleared WCEs was determined by Bradford assay, using BSA (1.8-
25 μg/mL) as a standard.  
Anti-Taf12p immunoprecipitations.  Each immunoprecipitation consists 
of the following: 550 μg of pre-cleared WCE, 0.025 μg/ μL EthBr, antibody, and lysis 
buffer to bring the final volume of the reaction to 200 μL. The antibodies consisted of one 
of  the following: ten μg of 12CA5 cross-linked to Protein A sepharose beads, 10.5 μg  of 
nonspecific rabbit IgG cross-linked to Protein A sepharose beads, and ten μg of free 
polyclonal anti-Taf12p. In those immunoprecipitations containing free antibody, five μL 
of Protein A sepharose were added. Immunoprecipitations were generally incubated on a 
tiltboard in the cold room for 14 hours (overnight), except for one set of experiments in 
which the immunoprecipitations were incubated for seven hours. The shorter duration of 
the reaction did not affect the co-immunoprecipitation of Swi6p with Taf12p. 
Immunoprecipitates were harvested by a one minute spin at 12krpm in the cold room. 
Each immunoprecipitate was washed three times with lysis buffer, 500 μL of lysis buffer 
per wash.  
Anti-Taf4p immunoprecipitations.  Swi6p was not detected in the anti- 
Taf4p immunoprecipitate when the experiment was performed as described above for 
anti-Taf12p immunoprecipitations, so the reaction was scaled up and the experiment was 
performed as described in this section. Each immunoprecipitation consisted of 950 µg of 
pre-cleared WCE, 0.025 µg/ µL EthBr, antibody, and lysis buffer to bring the final 
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 volume of the reaction to 400 µL. Each reaction contained 20 µg of either polyclonal 
anti-Ta4p or nonspecific rabbit IgG (both were cross-linked to CNBr-activated sepharose 
beads). Immunoprecipitations were incubated for 16 hours (overnight) in the cold room 
on a tiltboard. Immunoprecipitates were harvested with a one minute spin in the cold 
room at 12krpm, and each immunoprecipitate was washed twice with lysis buffer, 700 µL 
of buffer each wash.  
SDS-PAGE analysis and immunoblot of immunoprecipitations.  The  
immunoprecipitate was solubilized in LDS PAGE sample buffer for ten minutes in a 
boiling water bath or in a 100◦C heating block, cooled at room temperature for ten 
minutes, and spun briefly at 12krpm to recover condensate. Inputs and portions of the 
immunoprecipitates were subjected to SDS-PAGE analysis. Samples were loaded on a 4-
12% gradient bis-Tris gel, and run in 1xMOPS-SDS running buffer for 50 minutes to one 
hour at 200V. Proteins were electroblotted onto PVDF (0.45 μM) for two hours at 12V in 
1x transfer buffer/10% methanol (v/v). Membranes were blocked in 10%  milk/TBS-T 
for one to two hours at room temperature, and incubated in primary antibody overnight 
on a tiltboard in the cold room. Antibodies used in detection were: polyclonal anti-Taf11p 
(1:5000 or 1:3300); anti-HA cross-linked to HRP (1:2000); polyclonal anti-Taf12p 
(1:10,000); polyclonal anti-Taf4p (1:2500); and polyclonal anti-Swi6p (1:5000). All 
blots, except those probed with anti-HA HRP, were rinsed once in 1% milk/TBS-T, 
washed three times in TBS-T, and incubated with goat anti-rabbit Fab cross-linked to 
HRP, 1:20,000 in 1% milk/TBS-T, for 30 minutes at room temperature. Then, all blots, 
including those probed with anti-HA HRP, were rinsed and washed as described above. 
Protein was visualized with enhanced chemiluminescence, and signals were either 
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 detected directly with a ChemiDoc XRS scanner or by exposure to Kodak BioMax Light 
film.  
Some blots probed with anti-Swi6p and anti-HA HRP were stripped and re-
probed with either polyclonal anti-Swi6p at a higher concentration (1:3300) or with a 
fresh lot of anti-HA cross-linked to HRP at 1:2000.   The blots were stripped in stripping 
solution for 30 minutes in a 65°C water bath and washed four times with TBS-T. The 
stripped blots were then probed with primary antibody and processed as described above.  
Films of immunoblots were scanned with a regular light scanner. Scanned films 
or blots detected directly with a ChemiDoc XRS scanner were analyzed in Quantity One 
software (Biorad) with the volume rectangle tool. Immunoprecipitation efficiency was 
calculated for a given protein as follows: immunoprecipitation efficiency of protein X = 
{100/% of immunoprecipitate subjected to immunoblot * [(adjusted volume of protein X 
in immunoprecipitate /adjusted volume of protein X in input)* %input]}. If, for a given 
protein, there was any background signal detected in the negative control (the rabbit IgG 
immunoprecipitations), then the adjusted volume of this background signal was first 
subtracted from the adjusted volume of the signal detected in the anti-TafII 
immunoprecipitations; this corrected value was then used instead in the formula 
described above. 
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 SDS-PAGE analysis of total protein in WCE.  Pre-cleared portions of  
yeast WCE were subjected to SDS-PAGE analysis as described above, and the resulting 
gel was either stained with Coomassie or with Sypro Ruby.  
Coomassie staining was performed as follows: the gel was stained with 
microwave-heated Coomassie stain (0.05% w/v Coomassie Blue R-250 in 10% v/v acetic 
acid and 25% v/v isopropanol) for 40 minutes, and destained twice (40 minutes per 
incubation) with 40%v/v methanol and 10%v/v acetic acid. The gel was scanned with a 
regular light scanner, lane analysis was performed with Quantity One software, and lane 
intensities were plotted with Microsoft Excel.  
Sypro Ruby staining was performed as follows: the gel was fixed twice in 50% 
methanol(v/v)/7% acetic acid (v/v) (15 minute each incubation), stained with Sypro Ruby 
protein gel stain (Molecular Probes, Invitrogen) overnight for 22 hours, and destained 
with 10% methanol (v/v)/7% acetic acid (v/v) for 30 minutes. The gel was then scanned 
with a Molecular Imager FX scanner. The gel was analyzed further in Quantity One with 
a volume rectangle tool. The entirety of each lane had been enclosed in volume boxes of 
equivalent length and width.  
 
 Growth curve analysis of wild-type and taf9W133stop yeast 
Yeast cells were streaked and incubated on YPAD plates containing G418 at 
30°C for three days.  Cells from the following glycerol stocks were streaked on separate 
plates: the lab cognate wild-type stock, my own cognate wild-type stock derived from the 
lab wild-type stock, the lab taf9W133stop stock, and my own taf9W133stop stock derived 
from the lab taf9W133stop stock. Single colonies from each plate were inoculated in 
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 separate, 5mL-YPAD starter cultures containing G418. Four wild-type colonies were 
inoculated in separate liquid cultures (two colonies per glycerol stock), whereas 20 
taf9W133stop clones were inoculated in separate liquid cultures (10 colonies per glycerol 
stock). These cultures were grown to saturation. For each clone, two OD of the starter 
culture was inoculated into 15 mL of fresh liquid YPAD media. Immediately after 
inoculation, the initial OD600 of each 15mL-culture was measured with duplicate samples. 
The 15mL-cultures were then grown at 30°C, with shaking at 200rpm. The growth of the 
culture was monitored by OD600. At each time point, measurements of duplicate samples 
of each culture were taken. Initially, measurements were taken of samples of culture 
without dilution, but when readings of the culture surpassed a value of 1, measurements 
were taken of a sample of the culture that had been diluted 1:10 in YPD.  
 
Co-immunoprecipitation analysis in 21R wild-type and 21R Taf9p-HA3 yeast  
     strains  
 
    Lysis buffer consisted of the following: 20mM HEPES pH 7.9; 10% glycerol 
(v/v); 300mM or 150mM NaCl; 1mM DTT; 0.1% NP-40; and one complete mini-
protease inhibitor tablet (Roche) per ten mL of buffer. Stripping solution consisted of the 
following: 2% SDS (w/v), 30mM Tris acetate pH 6.7, and 100mM β-mercaptoethanol. 
Tris-buffered saline with Tween-20 (TBS-T) consisted of the following: 25mM Tris-HCl 
pH 7.6; 150mM NaCl; and 0.05% Tween-20 (v/v). 20X Transfer buffer consisted of the 
following per liter of buffer: 81.6 g bicine; 104.8 g bis-Tris; 6.0 g EDTA; and 0.2g 
chlorobutanol 
Each strain was grown as follows: yeast were streaked from frozen glycerol 
stocks onto YPAD plates containing G418 (21R Taf9p-HA3) or YPAD alone (21R wild-
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 type) and incubated at 30ºC for about a day and a half. A single colony from the plate 
culture was inoculated into a starter culture of 5mL YPAD and incubated, with shaking at 
250rpm, at 30ºC until the culture became saturated.  A starter culture was inoculated into 
100 mL of YPAD so that the starting OD600/mL was about 0.125 OD600/mL. The 100mL 
culture was incubated at 30ºC, with shaking at 250rpm, until the culture reached an 
OD600/mL of about 1.3-1.5 OD600/mL. Two 50mL-aliquots were collected in 50mL-
conical tubes (Falcon) and harvested by centrifugation in a Beckman centrifuge for 10 
minutes at 4°C. The pellets were washed once with 25 mL of cold phosphate buffered 
saline (PBS). Each pellet was suspended in one mL of PBS, transferred to 1.5mL-screw 
top tubes (Sarstedt) and pelleted by spinning for three minutes at 6500 rpm in a 
microfuge. The supernatant was discarded, the pellet was frozen on dry ice, and stored at 
-70°C.  
 WCE was obtained from each cell pellet as follows:  the cell pellet was thawed 
on ice from -70°C, and then beat with a mini-bead beater with 500 μL of glass beads and 
600 μL of lysis buffer (containing 300mM NaCl) in the cold room. The cells were beat 
for a total of four cycles, with each cycle consisting of beating for 30 seconds, followed 
by incubation on ice for two minutes. The pellets were then agitated for 30 minutes in an 
IKA-Vibrax-VKR vibrator in the cold room at a setting of 2200. The pellets were beat 
again with a bead beater as described above for two additional cycles. Finally, the pellets 
were agitated in the vibrator as described above for an additional 15 minutes. Five μL of 
each lysate were examined with an Olympus light microscope, and the lysis efficiency 
was determined by visual inspection to be over 90-95%. Four hundred μL of WCE was 
obtained by spinning the lysate for 10 minutes at 14krpm in the cold room in a 
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 microfuge. The WCE was then pre-cleared with 175 μL of a 1:1 slurry of Protein A 
Sepharose in lysis buffer for five minutes on a tiltboard in the cold room. Four hundred 
and eighty μL of pre-cleared WCE was obtained by spinning for two minutes at 6krpm in 
the cold room. The protein concentration of the pre-cleared extract was measured by 
Bradford assay. BSA, over a concentration range of 2μg/mL-20 μg/mL, was used as a 
standard in the Bradford assay.  
  Each immunoprecipitation consisted of the following: 540 μg of pre-cleared 
WCE, antibody, 0.025 μg/ μL EthBr, and lysis buffer to bring the final volume of the 
reaction to 200 μL. The antibody used was 12 μg of 12CA5 antibody cross-linked to 
agarose. As a negative control, some immunoprecipitations were performed without 
antibody; in these reactions, five μL of Protein A-sepharose were added instead. In 
addition, the lysis buffer added to raise the volume of each reaction had a NaCl 
concentration of either 300mM or 150mM. 
In general, the immunoprecipitations were incubated for 14-20 hours (overnight) 
in the cold room on a tiltboard. The pellets were harvested by a rapid one minute spin in 
the microfuge. The pellets were then washed three times with lysis buffer, 500 μL each 
wash. The pellet was then suspended in LDS PAGE sample buffer, and heated in a 75°C 
heating block for five minutes. The samples were cooled for five minutes at room 
temperature, and spun briefly in a microfuge at room temperature to bring down 
condensate. A portion of the immunoprecipitates was then analyzed by SDS-PAGE 
followed by immunoblot.  
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SDS-PAGE analysis and immunoblot of immunoprecipitations. Portions  
of pre-cleared WCE (inputs) and of the LDS-solubilized immunoprecipitates were 
analyzed further by SDS-PAGE and immunoblot. Each input consisted of an amount that 
was equal to 1% of the total protein that was subjected to immunoprecipitation. Inputs 
and immunoprecipitates were electrophoresed on a 4-12% gradient bis-Tris gel for one 
hour at 200V. Protein was electroblotted onto a 0.45μM PVDF membrane in 1x transfer 
buffer/10% methanol (v/v) for over two hours at 12V. The membrane was blocked for 
two hours in 10% nonfat milk/TBS-T and incubated with polyclonal anti-Swi6p (see 
Chapter II) at 1:5000 in 1% milk/TBS-T overnight in the cold room. The blots were then 
rinsed three times with TBS-T, incubated with goat anti-rabbit Fc cross-linked to 
horseradish peroxidase (HRP) for 45 minutes, and rinsed again with TBS-T three times. 
The protein was visualized with enhanced chemiluminescence and the images were 
detected by exposure of the membrane to Kodak BioMax Light film.  
Blots probed with anti-Swi6p were stripped and re-probed with either polyclonal 
anti-Taf8p at 1:10,000 or anti-HA cross-linked to HRP at 1:2000.  The blots were 
stripped in stripping solution for 40 minutes in a 65°C water bath and washed four times 
with TBS-T. The stripped blots were then probed with primary antibody and processed as 
described above, except that the blots were incubated with primary antibody at room 
temperature for four to seven hours, and the anti-HA blots were not incubated with 
secondary antibody.  
Films of immunoblots were scanned with ChemiDoc XRS and analyzed in 
Quantity One software (Biorad) with the volume rectangle tool. Immunoprecipitation 
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 efficiency was calculated for a given protein as follows: immunoprecipitation efficiency 
of protein X = {100/%  of immunoprecipitate subjected to immunoblot * [(adjusted 
volume of protein X in immunoprecipitate/adjusted volume of protein X in input) * 
%input]} 
 
 Results  
 
Swi6p interaction with TafIIs in taf9W133stop yeast 
 The initial Swi6p-TFIID co-immunoprecipitation experiments were performed by 
Steven Sanders in our laboratory. Through these experiments, he found that Swi6p co-
immunoprecipitated with some TafIIs (Taf8p, Taf12p, and Taf7p) and that this 
association was disrupted in taf9W133stop yeast (12).  
I successfully repeated the experiment with polyclonal anti-Taf12p antibodies. In 
addition, I modified the experimental procedure, using a much lower concentration of salt 
(150mM NaCl) than had been used by Sanders (300mM potassium acetate). Under these 
mild salt conditions, I found that polyclonal antibodies raised against Taf12p were able to 
specifically immunoprecipitate Swi6p as well as another TFIID subunit, Taf11p, from 
yeast WCEs. Furthermore, interaction between Swi6p and Taf12p was disrupted in 
taf9W133stop yeast. However, the interaction between Taf12p and Taf11p was not 
disrupted in this mutant (Figure III-1). These results are in agreement with what has been 
previously published (12). My co-immunoprecipitation results also suggest that the 
association between Taf12p and Swi6p is sub-stoichiometric since the efficiency by 
which anti-Taf12p antibodies can co-immunoprecipitate Swi6p is 3.5-5% in the wild-type 
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 strain. The immunoprecipitation efficiency, with respect to Taf12p, was 38%, so that the 
low levels of Swi6p detected in the immunoprecipitate may not likely be attributed to 
insufficient capture of antigen. Furthermore, the immunoprecipitation efficiency, with 
respect to Taf12p, was similar in the taf9W133stop WCEs, at 34%. Lastly, as indicated 
by the inputs, the expression levels of the Swi6p and of Taf12p were similar between 
wild-type and mutant WCEs.  
 The results of these experiments are consistent with the interpretation that the 
taf9W133stop mutation decreases the affinity of TFIID for interaction with Swi6p. 
However, I made some other observations that led me to revise this interpretation. 
First, I soon discovered that the observation that the Swi6p-TafII interaction was 
disrupted in taf9W133stop yeast was not reproducible. In further repeats of the anti-
Taf12p immunoprecipitation, I observed that interaction between Swi6p and Taf12p in 
taf9W133stop yeast WCEs was similar to wild-type (Figure III-2). Anti-Taf12p was able 
to co-immunoprecipitate Swi6p with an efficiency of 6% in the wild-type and 4.5% in the 
mutant. Again, as indicated by the inputs, the expression level of Swi6p-HA3 in wild-type 
and mutant input WCEs was the same.  
Second, I isolated a taf9W133stop mutant clone that expressed lower levels of 
TafIIs and Swi6p relative to wild-type. In another repeat of this experiment, I had 
successfully co-immunoprecipitated Swi6p with polyclonal anti-Taf4p antibodies in wild-
type yeast (Figure III-3).  I found that, in one mutant clone (mutant B), the co-
immunoprecipitation of Swi6 was unaffected, whereas, in a second mutant clone (mutant 
A), the co-immunoprecipitation of Swi6p was reduced. But, most importantly, the 
expression levels of Taf4p and of Swi6p were also reduced in the inputs in mutant A 
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 relative to wild-type. The level of Swi6p in  mutant A was 26% of wild-type, and Taf4p 
was not even detected in the input in mutant A. I observed that the level of another TafII, 
Taf12p, was reduced as well, with a mutant level that was 21% of wild-type (Figure III-
3a, b). In contrast, the expression of Swi6p and TafIIs in mutant B was similar to wild-
type.  
Also, analysis of the growth curves revealed that, at the permissive temperature, 
mutant A grew slower wild-type and mutant B (Figure III-3c). This was the first time I 
had isolated a mutant clone that grew slower than wild-type; previously, I had noted that 
the taf9W133stop yeast always grew at a rate similar to wild-type. However, the original 
description of taf9W133stop yeast by the Andrews lab had also noted that the mutant 
grows slower than wild-type at permissive temperature (18).   
To summarize, I have observed three phenotypes of the taf9W133stop mutant. In 
one phenotype (type A), interaction between Swi6p and the TafIIs are reduced, the 
expression levels of Swi6p and some of the TafIIs are reduced, and the growth rate is 
slower than wild-type.  In the second phenotype (type B), interaction between Swi6p and 
TafIIs is intact, and the expression levels of Swi6p and some of the TafIIs and the growth 
rate is similar to wild-type. In the third phenotype (type C), interaction between Swi6p 
and TafIIs is reduced, but the expression levels of Swi6p and some of the TafIIs and the 
growth rate is similar to wild-type. See Table III-2 for a summary of the various 
phenotypes of the taf9W133stop mutant. 
I hypothesized that the most severe phenotype of mutant A was the result of the 
taf9W133stop mutation alone, whereas phenotypes of mutant B and C were the result of 
the taf9W133stop mutation and mutations that were acquired during logarithmic growth. I 
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Figure III-1.
 88
  
 
Figure III-1. The interaction of Swi6p-HA3 withTaf12p is disrupted in yeast bearing 
the taf9W133stop mutation. a, b. Yeast WCE was immunoprecipitated with polyclonal 
anti-Taf12p antibodies for 14 hours, and the immunoprecipitate was analyzed by SDS-
PAGE and immunoblot. Shown in panels a. and b. are the results of two separate 
immunoprecipitation experiments. The proteins that were probed in the 
immunoprecipitate are indicated on the right. The number beneath inputs indicates the 
percentage of total protein subjected to immunoprecipitation, whereas the numbers 
beneath the immunoprecipitates indicates the percentage of the volume of LDS-
solubilized immunoprecipitate that was subjected to immunoblot analysis. The protein 
signals in the inputs and immunoprecipitates had been detected by exposure to Kodak 
Biomax Light film. The labels directly above each lane denote the yeast strain.  
IP=immunoprecipitate, Nonsp. IgG = nonspecific rabbit IgG,  
Prot. A Seph. = protein A sepharose. 
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Figure III-2.  
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 Figure III-2.  The interaction between Swi6p-HA3  and Taf12p was not always 
impaired in taf9W133stop yeast.  Yeast WCE was immunoprecipitated with polyclonal 
anti-Taf12p for seven hours, and the immunoprecipitate was analyzed by SDS-PAGE and 
immunoblot. The proteins that were probed in the immunoprecipitate are indicated on the 
right.  0.3 µg of purified yeast TAP-tagged TFIID had also been analyzed by SDS-PAGE 
and immunoblot in an adjacent lane. The number beneath inputs indicates the percentage 
of total protein that had been subjected to immunoprecipitation. Note that the number 
beneath each immunoprecipitate refers to the percentage of the combined volume of two 
LDS-solubilized immunoprecipitates that had been harvested from two identical  
immunoprecipitations performed in parallel. Two immunoprecipitates had been 
combined in order to increase the otherwise faint signal of Swi6p-HA3 in the 
immunoprecipitate. The protein signals in the inputs and immunoprecipitates had been 
detected directly with a ChemiDoc XRS scanner. The labels directly above each lane 
denote the yeast strain. 
 IP=immunoprecipitate, Nonsp. IgG = nonspecific rabbit IgG. 
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Figure III-3.  
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Figure III-3.  
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 Figure III-3. A taf9W133stop mutant was isolated that showed reduced protein 
expression levels and  slower growth relative to wild-type.   
In a. and b., the protein signals in the inputs and immunoprecipitates had been detected 
directly with a ChemiDoc XRS scanner. The labels directly above each lane denote the 
yeast strain.  
a. Yeast WCE was immunoprecipitated with polyclonal anti-Taf4p antibodies, and the 
immunoprecipitate was analyzed by SDS-PAGE and immunoblot.  A taf9W133stop  
mutant (mutant A) was isolated that showed reduced levels of Swi6p-HA3 and Taf11p in 
an anti-Taf4p immunoprecipitate, and reduced levels of Taf4p in the input. The number 
(in %) to the side of each input indicates the percentage of total protein subjected to 
immunoprecipitation, whereas the numbers (in %) to the side of each  immunoprecipitate 
indicates the percentage of the volume of LDS-solubilized immunoprecipitate that was 
subjected to immunoblot analysis. The labels directly above each lane denote the yeast 
strain. The proteins that were probed for in the immunoprecipitate are indicated to the 
right of each data panel. IP=immunoprecipitate, Nonsp. IgG = nonspecific rabbit IgG. 
b. Expression levels of Taf12p and Swi6p-HA3 were also reduced in the inputs of mutant 
A relative to wild-type. In each lane, 22 μg of WCE had been analyzed (based on 
concentrations determined by Bradford assay).  
c. The taf9W133stop isolate, mutant A, showed a slower growth at the permissive 
temperature (30°C) compared to a possible revertant of the taf9W133stop mutation 
(mutant B) and two wild-type clones. 
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 tested this hypothesis by monitoring the growth of multiple taf9W133stop clones in liquid 
culture at the permissive temperature. I measured the growth rate of four wild-type clones 
from two wild-type glycerol stocks, the lab stock and my own stock derived from the lab 
stock (two clones per glycerol stock). I also measured the growth rate of twenty 
taf9W133stop clones from two taf9W133stop glycerol stocks, the lab stock and my own 
stock derived from the lab stock. I performed this experiment in this way because I had 
used my glycerol stocks exclusively to grow yeast that were used in the anti-Taf12p 
immunoprecipitations, and I had used both the lab glycerol stocks and my own glycerol 
stocks to grow yeast that were used in the anti-Taf4p immunoprecipitations. I would like 
to point out that the mutant A phenotype had been observed in yeast grown from the lab 
taf9W133stop glycerol stock, whereas the mutant B and C phenotypes had been observed 
in yeast grown from my taf9W133stop stock.  
I monitored the growth of each culture by measuring OD600 until the rate of 
change in OD600 plateaued for that culture. Analysis of the growth curves led to several 
striking observations (Figure III-4). First, there was very little variation in the growth 
curves of the four wild-type clones. Second, nine of the taf9W133stop clones grew at the 
same rate as the wild-type clones, and again, there was very little variation in the growth 
curves of these clones. I noted that all nine of these clones were from my taf9W133stop 
stock. Third, eleven of the taf9W133stop clones showed significantly slower growth than 
wild-type.  I noted that one of these clones were from my taf9W133stop stock whereas 
the rest were from the lab taf9W133stop stock. Fourth, there was a broad variation in the 
growth curves of these slow-growing eleven clones. Taken together, these observations 
indicate that the taf9W133stop mutants do revert to wild-type growth at a high rate. Only 
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 one out of ten clones from my taf9W133stop stock grew slowly whereas the rest showed 
growth similar to wild-type. My taf9W133stop stock had been created from a 
logarithmically growing yeast culture that had been inoculated with a single colony from 
the lab taf9W133stop stock. This means that, in my taf9W133stop stock, nine out of ten 
colonies had reverted to wild-type growth. The broad variation in the growth curves of 
the mutant clones from the lab taf9W133stop stock suggests that a proportion of the cells  
in some cultures had reverted to wild-type growth or that the cells had acquired mutations 
that only partly restored wild-type growth. Thus, the variation in the growth curves may 
reflect different percentages and/or extents of reversion in each culture.  
As noted above, the expression of some TafIIs and Swi6p was reduced in the 
slow-growing mutant clone. To test whether this observation was specific to only these 
proteins, I analyzed the total protein in the WCEs of wild-type yeast and in taf9W133stop 
mutant clones A and B. The concentrations of each WCE were determined by Bradford 
assay, with BSA as a standard. The concentration of WCE, as determined by Bradford, 
was virtually the same for wild-type and mutants A and B (average of two wild-type 
clones was 1.905 μg/μL, mutant A was 1.91 μg/μL, and mutant B  was1.90 μg/μL  ).  
Next, I performed SDS-PAGE analysis of equal volumes of each WCE. The 
resulting gels were stained with either Coomassie R-250 or Sypro Ruby, and the stained 
gels were scanned with a regular light scanner or an FX laser scanner, respectively 
(Figure III-5). Quantitation of  the total protein in the Sypro Ruby-stained gel showed 
that the total protein in mutant A WCE was reduced from wild-type by  33%, whereas the 
total protein in mutant B WCE was increased from wild-type by 2%. .  
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Figure III-4. 
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 Figure III-4. Growth curve analysis of taf9W133stop clones from two glycerol stocks. 
(Top) Nine of ten taf9W133stop clones from one glycerol stock grew like wild-type. 
(Bottom) All ten taf9W133stop clones from another glycerol stock grew slower than 
wild-type. Data for the same four wild-type clones are shown in both graphs. 
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Figure III-5.  
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Figure III-5.  
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 Figure III-5. There was a global reduction of protein levels in the slow-growing 
taf9W133stop isolate, mutant A.   
a. Shown is a Coomassie stain of WCEs from two wild-type clones and taf9W133stop 
mutants A and B. For each clone, four lanes of WCE of decreasing amounts of protein, 
from left to right, were loaded. For each clone, the following volumes of LDS-solubilized 
WCE were loaded (left to right): 10 μL, 5 μL, 2.5 μL, and 1.3 μL.  
b. A plot of a., comparing the levels of intensity in the lanes in which 10 μL of protein 
had been loaded. “Relative front” refers to equivalent positions in each lane analyzed.  
c. Sypro Ruby stained gel of WCEs from two wild-type clones and  taf9W133stop 
mutants, A and B. In each lane, 1 μL of LDS-solubilized WCE was loaded. 
In a. and c., the numbers to the left of each gel are the MWs, in kDa. 
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 It is not unusual that protein concentrations determined by Bradford and by gel 
analysis of the same sample are not equivalent. Previous work in the literature has shown 
that the Bradford assay is sensitive to differences in overall concentration of positive 
charges in the proteins being measured (32). Therefore, it is possible that, although the 
protein expression levels in taf9W133stop clone A was reduced, the concentration 
determined by Bradford assay is similar to wild-type due to changes in the overall charge 
of cellular protein.  
Differences in the quantities of protein released during preparation of the WCE 
are unlikely as all yeast were beaten with glass beads until the lysis efficiency was over 
95% (see Materials and Methods). Furthermore, wild-type and all taf9W133stop yeast 
were of the same size and morphology, so that harvesting equivalent OD600 of wild-type 
and taf9W133stop yeast was equivalent to harvesting equivalent numbers of cells of wild-
type and taf9W133stop yeast.   
Of course, there are other, more rigorous ways in which levels of overall protein 
expression in a cell can be measured. For example, one such method is measuring the 
concentration of DNA in WCE. DNA concentration would be expected to be the same in 
both a wild-type and mutant yeast cell. Therefore, DNA concentration in wild-type and 
mutant WCEs would be the same if the same number of cells was harvested, and the 
extent of cell breakage and release of intracellular contents were the same for wild-type 
and mutant yeast.  Therefore, if levels of protein expression inside a mutant cell are really 
decreased relative to wild-type, then the difference in protein concentration of the mutant 
WCE should persist even after normalizing for DNA concentration. However, due to time 
constraints, I am unable to perform these analyses. 
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 In summary, I have shown that Swi6p interacts with Taf12p and Taf4p in wild-
type WCE. I had repeated an observation made by Steven Sanders, that the interaction 
between Taf12p and Swi6p was reduced in yeast harboring a taf9W133stop mutation. I 
isolated a slow-growing taf9W133stop clone, mutant A, that showed reduced interaction 
between Taf4p and Swi6p, but also showed reduced expression of Taf4p and Swi6p in 
the WCE. In addition, Taf12p expression was reduced in the WCE as well.  Overall, I 
found that protein expression was reduced globally in this mutant. In addition, I found 
that taf9W133stop yeast revert to wild-type growth at a high frequency during 
logarithmic growth. The initial interpretation of Sanders’ data had been that the 
taf9W133stop mutation lowered the affinity of TFIID for Swi6p. Analysis of my data also 
leads me to speculate that the taf9W133stop mutation somehow affects levels of protein 
synthesis as well.  
Co-immunoprecipitation of Swi6p and Taf9p from yeast WCE 
I had initially hypothesized that Taf9p serves as a coactivator for Swi6p. One of 
the first questions I attempted to answer was whether Taf9p interacted with Swi6p in 
vivo. To answer this question, I performed immunoprecipitations in yeast WCE. The lack 
of suitable polyclonal anti-Taf9p antibodies for immunoprecipitation precluded me from 
performing anti-Taf9p immunoprecipitations directly in wild-type yeast; therefore, I 
carried out immunoprecipitations in yeast that expressed Taf9p-HA3 using 12CA5 
monoclonal antibodies (12CA5 antibodies specifically recognize the HA epitope).  
The immunoprecipitation efficiency of 12CA5 with respect to Taf9p-HA3 was 
49%, regardless of salt concentration, 150mM or 300mM NaCl (Figure III-6a and Figure 
III-6b). However, Swi6p did not co-immunoprecipitate under these conditions at either 
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 salt concentration (Figure III-6a and III-6b). As a positive control, Taf8p was probed in 
these immunoprecipitates, and it was found that Taf8p did co-immunoprecipitate with 
Taf9p-HA3 under these conditions, regardless of salt concentration.  
Furthermore, as discussed in the preceding section, Swi6p co-immunoprecipitated 
with Taf12p in reactions in which the immunoprecipitation efficiency of the polyclonal 
anti-Taf12p antibodies, with respect to Taf12p, was 38%. Since the immunoprecipitation 
efficiency of Taf9p-HA3 was even greater (at 49%) in these experiments, the inability of 
Swi6p to co-immunoprecipitate with Taf9p-HA3 was not likely due to insufficient 
capture of antigen.  
The inability of Swi6p to co-immunoprecipitate with Taf9p-HA3 was also not 
likely due to degradation of Swi6p because Swi6p was detected, at comparable levels, in 
the 12CA5 immunoprecipitates from both wild-type and Taf9p-HA3 strains (Figure III-
6c).  
In summary, I found that Swi6p did not co-immunoprecipitate with Taf9p- HA3 
under conditions in which another TafII, Taf8p, could co-immunoprecipitate with Taf9p-
HA3. The inability to co-immunoprecipitate is not likely due to low immunoprecipitation 
efficiency, since Swi6p co-immunoprecipitated with Taf12p in immunoprecipitations 
where the efficiency of the anti-Taf12p antibody was lower than the efficiency of 12CA5 
(see Swi6p interaction with TafIIs in taf9W133stop yeast). Also, the inability to co-
immunoprecipitate is unlikely due to degradation of Swi6p, as Swi6p was detected, at 
comparable levels, in 12CA5 immunoprecipitates of both wild-type and Taf9p-HA3 yeast. 
As discussed in Chapter I, the taf9W133stop mutation results in the truncation of 
Taf9p at the C terminus. The inability of Swi6p to co-immunoprecipitate with TafIIs in 
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 taf9W133stop yeast suggests that the C terminus of Taf9p is important in mediating 
interaction between TFIID and Swi6p. The inability of Swi6p to co-immunoprecipitate 
with Taf9p-HA3 indirectly supports the notion that the C terminus of Taf9p is important 
for mediating interaction between Swi6p and Taf9p-HA3 because it is possible that an 
HA tag at the C terminus of Taf9p-HA3 blocks the interaction between Swi6p and TFIID. 
If this is the case, then Swi6p should be able to co-immunoprecipitate with Taf9p that has 
been tagged at the N terminus only.  
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 Figure III-6. Swi6p does not co-immunoprecipitate with Taf9p-HA3.  Pre-cleared 
yeast WCE was immunoprecipitated with 12CA5 monoclonal antibodies, and the 
immunoprecipitate was analyzed by SDS-PAGE and immunoblot. The number beneath 
inputs indicates the percentage of total protein subjected to immunoprecipitation, whereas 
the numbers beneath the immunoprecipitate indicates the percentage of the volume of 
LDS-solubilized immunoprecipitate that was subjected to immunoblot analysis. The 
labels directly above each lane denote the yeast strain. The proteins that were probed for 
in the immunoprecipitate are indicated either to the right or left of each data panel. 
IP=immunoprecipitate. 
a. Shown are immunoprecipitates and inputs probed with anti-Swi6p or stripped and re-
probed with anti-Taf8p. The immunoprecipitates depicted in this panel were in 300mM 
NaCl.  
b. Shown are immunoprecipitates and inputs probed with anti-Swi6p or stripped and re-
probed with either anti-Taf8p or anti-HA HRP.  The immunoprecipitations depicted in 
this panel were performed in either 150mM or 300mM NaCl. “150mM” and “300mM” 
refer to NaCl concentrations. 
c. Swi6p did not degrade over the course of the 12CA5 immunoprecipitation. Shown is 
an immunoblot of 67% of an immunoprecipitate.   
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 Discussion 
During the course of performing the anti-Taf12p and anti-Taf4p 
immunoprecipitations, I observed three types of taf9W133stop  phenotypes. These are 
summarized in Table III-2. 
The taf9W133stop mutant varied in terms of interaction between Swi6p and the 
TafIIs, expression levels of cellular protein, and growth rate.  I propose the following 
model (Figure III-7). The taf9W133stop mutation has such pleiotropic effects in the cell 
because Taf9p is important for mediating transcriptional activation by at least two 
transcription factors, Rap1p and the Swi6p-containing complex, SBF.  Rap1p mediates 
transcription of ribosomal protein genes. Therefore, the reduction in cellular protein may 
be due to a defect in transcription of ribosomal protein genes. SBF, on the other hand, 
mediates transcription of genes that are important for regulating the cell cycle. Therefore, 
the longer cell cycle may be due to a defect in transcription of these genes. The slow 
growth may be due to both the reduction in cellular protein and to reduced expression of 
genes that regulate the cell cycle. During the course of logarithmic growth, some 
taf9W133stop clones acquire mutations that restore wild-type growth and that restore 
wild-type levels of protein expression. Some of these acquired mutations also restore 
interaction between SBF and Taf12p and Taf4p, whereas other mutations restore wild-
type growth and wild-type levels of protein expression but do not restore interaction 
between Swi6p and these TafIIs. Both recent work performed by others in our laboratory 
and work done by me support this model. 
First, recent work in our laboratory has shown that TFIID serves as a coactivator for 
Rap1p at ribosomal protein genes, and that transcription of a ribosomal protein gene, 
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 RPS5, is downregulated in a taf9 temperature sensitive mutant (33). Therefore, it is 
possible that the taf9W133stop mutation impairs the ability of Taf9p, and hence TFIID, to 
serve as coactivator for Rap1p. 
Second, my own data suggests that TFIID may serve as a coactivator for SBF at the 
promoters of cell-cycle regulated genes. I have found that the Swi6p-containing complex, 
SBF, mediates direct interaction with a subset of TafIIs (Taf12p, Taf5p, and Taf4p). 
Furthermore, there is evidence that one of these TafIIs, Taf12p, regulates the expression 
of several cell-cycle regulated genes (discussed in Chapter II). Previous work and my 
own data had shown that the ability of Swi6p to co-immunoprecipitate with TafIIs is 
reduced in the taf9W133stop mutant. By cryo EM, SBF interacts with a domain of TFIID 
that contains all the directly interacting TafIIs (Taf12p, Taf4p, and Taf5p) and Taf9p.  
Interestingly, Rap1p also interacts directly with Taf12p, Taf4p, and Taf5p. 
Furthermore, it was found that transcription of RPS5 was also regulated by Taf12p, 
Taf4p, and Taf5p. Finally, as for SBF, it was found that Rap1p interacts with domains of 
TFIID that contain all the directly interacting TafIIs (Taf12p, Taf4p, and Taf5p) and 
Taf9p (unpublished communications with collaborator, Patrick Schultz). 
However, I did not detect any direct interaction between SBF and Taf9p. 
Interestingly, no direct interaction was detected between Taf9p and Rap1p either. How 
can Taf9p play a role in regulating transcription of genes mediated by Rap1p and SBF if 
it does not directly interact with them? One can envision multiple mechanisms by which 
Taf9p may indirectly serve as a coactivator for Rap1p and SBF, none of which are 
mutually exclusive. First, Taf9p may stabilize interaction between Rap1p and SBF with 
Taf12p, Taf4p, and Taf5p. Second, Taf9p may mediate a conformational change in 
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 TFIID such that the binding surfaces of these TafIIs are exposed in the intact TFIID 
complex, thus enabling TFIID to engage Rap1p and SBF. Indeed, it has been proposed 
that Taf9p interacts with a Taf12p-Taf4p heterotetramer (34). Finally, in the case of SBF, 
it is also possible that Taf9p may interact with the other component of SBF, Swi4p, in a 
manner that does not depend on Swi6p. Such an interaction could have escaped detection 
in the Far Western assay (Figure II-15b and Discussion in Chapter II). 
Previous work in the literature shows that TFIID is involved in the transcriptional 
regulation of two fundamental cellular processes: ribosome biogenesis and cell cycle 
regulation. The work done by me and others in this laboratory suggests that TFIID 
performs this role by acting as a coactivator for two transcription factors, Rap1p and 
SBF, that regulate transcription of genes required for these processes. Furthermore, our 
work suggests that TFIID interacts with Rap1p and SBF through the same set of TafIIs 
(Taf12p, Taf4p, and Taf5p). In addition, Taf9p may modulate the interaction between 
TFIID and SBF.  The observations that global levels of protein expression is reduced in 
some taf9W133stop mutant clones and that transcription of RPS5 is downregulated in a 
taf9 ts mutant suggest that Taf9p may also modulate interaction between TFIID and 
Rap1p as well. It is striking that TFIID employs similar mechanisms to interact with two 
distinct transcription factors, but on reflection, not unusual. In eukaryotes, the activities 
of TOR kinase links cellular protein synthesis and cell cycle regulation (35). In a similar 
way, TFIID may be an example of another link that coordinates two cellular processes 
that are essential to cell survival.  
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 Figure III-7. The taf9W133stop mutation may affect both the transcription of 
ribosomal protein genes and cell-cycle regulated genes.  
a. Taf9p (dark pink sphere) may play a role in transcription mediated by Rap1p and SBF 
indirectly, through stabilizing interaction between both transcription factors and other 
TafIIs, or by altering conformation of the interacting TafIIs. In the case of SBF, Taf9p 
may also mediate direct interaction with Swi4p. 
b. Mutant Taf9p (light pink sphere) is unable to participate in mediating transcription by 
Rap1p and SBF. As a consequence of the inability of the mutant Taf9p  to participate in 
transcription by Rap1p,  the levels of expression of ribosomal protein genes is decreased, 
which results in reduced global levels of protein synthesis. As a consequence of the 
inability of the mutant Taf9p to participate in transcription by SBF, the levels of 
expression of genes that regulate the cell cycle are reduced, which results in a longer cell 
cycle. The combination of a longer cell cycle and reduced level of protein synthesis leads 
to slow growth. However, TFIID still drives transcription, albeit to a lesser extent, 
because of the direct interactions between other TafIIs and both transcription factors. 
c. In the absence of Swi6p, TFIID is no longer able to drive transcription of cell-cycle 
regulated genes. The lack of expression of genes that are required for the G1/S transition 
results in the uniform arrest of yeast in G1. 
d. Compensating mutations in other genes restore TFIID’s ability to drive transcription 
mediated by Rap1p even in the presence of mutant Taf9p. These compensations restore 
wild-type levels of expression of ribosomal protein genes, which in turn leads to wild-
type levels of protein synthesis. These compensating mutations also restore wild-type 
growth. However, in the case of SBF, these mutations may or may not restore interaction 
between the other TafIIs and Swi6p, which explains why Swi6p co-immunoprecipitates 
with Taf12p and Taf4p in some yeast clones but not in others. However, the restoration 
of interaction between Ta9p and Swi4p makes up for this deficit. 
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